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Abstract
The design of  new systems featuring multi-functionalities  represents  a  key strategy in  meeting 
complex challenges in various domains including chemistry, medicine, environmental sciences, and 
technology. The present thesis describes the synthesis and characterization of new nanoreactors and 
polymeric brushes. 
Polymer brushes were used to improve the surface properties of interfaces by attachment to a solid 
supported  surface.  For  that  purpose,  PEG polymers  were  synthesized  by atom transfer  radical 
polymerization (ATRP). The polymeric brush was assembled on a gold surface using the grafting 
method. In this way the polymeric brush provides dual functionality as it is involved both in surface 
passivation and provides selective binding sites.
In a second project, nanoreactors, we described protein-containing polymer nanoreactors with dual 
functionality  designed  for peroxynitrite  degradation  and  oxygen  transport.  The  vesicles  were 
successfully prepared using PMOXA- PDMS- PMOXA tri blockpolymers. Hemoglobin (Hb) was 
encapsulated in the nanoreactors. It was used as a model protein because of its ability to provide the 
dual  function  of  oxygen transport  and peroxynitrite  degradation.  We proved that  Hb keeps its 
functionality  following  encapsulation.  The  insertion  of  channel  proteins  into  the  polymeric 
membrane of the vesicle allowed the passage of various compounds that served for the assessment 
of in situ Hb activity.
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1 Introduction
In Nature, polymers play a variety of different and important roles. The most famous biological 
polymer is deoxyribonucleic acid (DNA).1 It contains the information needed to create proteins. In 
addition, there is a wide variety of other polymers such as proteins or cellulose. Proteins are the ba­
sic building blocks of life; they feature a diverse variety of specific functions including transport of 
molecules, selective receptivity, signal transduction, and cell recognition. They provide anchoring 
sites to which cytoskeletal filaments or components of the extracellular matrix can connect. Further­
more, proteins can act as enzymes, structural components, or have hormonal activities.
Besides their  natural  variety of  properties  and functions,  they also allow for a  wide  variety of 
different applications that help to improve our everyday live.
The first studies related to polymers were done by Henri Braconnot, who did his pioneering work 
on derivatives of cellulose compounds.2 The first completely synthetic polymer was created by Leo 
Baekeland (Bakelit) hundred years later, in 1907.3
Since then,  many different  polymers have been synthesized and used for different applications. 
Examples for polymers that we come in contact with every day:
• poly(vinyl chloride), poly(styrene), poly(ethylene), poly(propylene), poly(acrylonitrile)
Because of their chemical nature, polymers offer a unique opportunity to create nano-sized objects 
such as nanoreactors and nanocarriers, which can be used in bio- and pharmaceutical sciences.
Polymers can also be used to modify the properties of various surfaces.
The simplest polymer architecture is a linear chain of repeating single units, or monomers – a single 
backbone with no branches – also referred to as a homopolymer4
In contrast to homopolymers that consist only of a single monomer, copolymers are made up of 
different kinds of monomers. Copolymers can be further divided into different subgroups.
The category to which a polymer belongs depends on the positioning of the different monomers in 
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the polymer.
Copolymers that consist of two different monomers can be divided into the following types:
- Statistical copolymers, where the sequence of the different monomers, A and B, follows a 
statistical rule (ABBAABBBA). 
- Alternating copolymers, where the sequence of monomers consists of alternating A and B 
monomers (ABABABABAB).
- Block copolymers, where the different monomers are arranged as blocks (AAAAABBBBB). 
The different blocks are linked together by covalent bonds.
The use of different monomers also allows the creation of polymer architectures with different 
features. When polymers comprise a main chain with one or more branches, they are referred to, for 
example,  as  star  polymers,  comb  polymers7,  brush  polymers,  hyper  branched  polymers,  and 
dendrimers.10
1.1.1 Solid supported polymer brush
One area in which polymers are used is surface modification. Polymer films are thereby deposited 
on a surface. Solid supported polymer films are used to improve the properties of water/surface- or 
air/surface interfaces.  Engineering such systems allows the formation of many different surface 
properties, such as adhesion, swelling and wetability, to be optimized. 
A polymer brush can be described as tethered, polymer chains that are densely attached to a sur­
face.11 If the density of the polymer brushes on the surface is high, the polymers are not able to form 
the same natural random-walk12 conformation as they would in solution.
In solution, polymer chains form a conformation in order to maximize the free energy of the system. 
Consequently, a polymer chain on the surface prefers the same conformation as in solution. 
However, if the grafting density is very low, there will not be a huge effect because the only steric 
hindrance  to  the  polymer  comes  from the  surface  and  by self-avoidance of  the  polymers.  In 
contrast,  if  the  grafting  density  of  the  polymer  chain  increases,  repulsive  forces  between  the 
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polymer chains also increases, due to the avoidance of overlaps. To minimize overlap, the polymer 
chains are forced to stretch away from the surface, leading to a  lowering of the configurational 
entropy.13
Solid supported polymer films can be formed with different covalent or non-covalent methods.
1.1.2 Non-covalent methods:
There  are  different  methods  to  create  non-covalent  bound  monolayers,  such  as  the  Langmuir-
Blodgett or LBL method.
For amphiphilic copolymers, the Langmuir Blodgett method is often used. The principle of this 
method is that amphiphilic copolymers form a self-assembling monolayer at the water-air interface. 
The hydrophilic part enters the aqueous phase and the hydrophobic part is pushed away from the 
water.  The  monolayer  is  transferred  to  a  given  surface  by immersing  that  surface  through the 
monolayer into the aqueous phase.
The density of the resulting polymer brush is limited to the density of the self-assembled monolayer. 
This method is often used for the preparation of monolayers. However, for the deposition of multi-
layered  structures,  the  Layer  by Layer  (LbL) method has  also been shown to  be suitable.  The 
method is based on the adsorption of polymers from a polymer-containing solution. For the LbL 
method, anionic and cationic charged polymers are used. 
By immersing the surface alternatingly in an anionic and cationic polymer solution, a well defined 
multilayer can be achieved.14 
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1.1.3 Covalent methods:
1.1.3.1 “Grafting to” method
To create covalent bound polymer brushes, two different strategies can be employed. One is the 
“grafting to” method, by which a polymer is synthesized in solution, and is then attached to the 
surface with an end functional group. The synthesis of these polymer chains is no different from the 
synthesis of polymers in solution, except for the end functional group, which is required to attach 
the polymer to the surface. Different surfaces require different end functionalized groups. To attach 
polymer brushes to a gold substrate, a disulfide or a thiol group is used, because it forms a covalent 
bond to the metal surface.  Many different surfaces can be used, including flat  surfaces such as 
silicon,  or  surfaces  having  a  complex  shape  such as  nanoparticles,  or  cellulose17. Synthesis  in 
solution allows the use of a wide variety of polymerisation techniques, such as free radical-, living 
radical-, ring opening- or anionic polymerisation. These result in a broad range of monomers being 
polymerizable.  Also,  oligonucleotide brushes can be formed in this  way.18 The grafting density 
depends on both the molecular weight of the polymer chain and the surface properties. Additionally, 
this density is influenced by some other parameters such as the reaction temperature or the grafting 
time. The grafting density can be controlled by varying these parameters. It is also possible to form 
a grafting gradient by creating a temperature gradient.19
One drawback of the “grafting to” method is that, compared to the “grafting from” method, the 
grafting density on the surface is lower. That is why the “grafting from” method is often used.20 
1.1.3.2 “Grafting from” method
In the “grafting from” method, the polymer is polymerized directly on the surface. The initiator for 
the  polymerisation  is  placed  on  the  surface  prior  to  the  polymerisation.  This  can  be  done  by 
immersing the surface in an initiator solution. One of the most commonly used methods is a living 
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radical polymerisation such as Nitroxide-mediated Radical Polymerization NMP or Atom Transfer 
Radical  Polymerisation  (ATRP).  ATRP  is  a  robust  method  and,  compared  to  free  radical 
polymerisation,  it  is  a  much  more  controlled  reaction.  This  effect decreases  the  problem  of 
polymers created during the same polymerisation process not  having the exact same molar mass, 
thereby leading to a smaller polydispersity. In addition, the functional group for the polymerisation 
can be in one  of two different states: the active and the dormant state.  In the active state new 
monomers add to the polymer chain.  And in the dormant state the functional group is not active; 
therefore, the polymer can be conserved and later reactivated, which offers the opportunity to create 
diblock or triblock copolymers.22
The length  of  the  polymer  chain  can  be  controlled  by the  reaction  time.  The grafting  density 
depends on the density of the initiator  molecules on the surface.  It  is  also possible  to create  a 
grafting gradient by generating a gradient in the initiator concentration.23
The “grafting from” method is often used because it is possible to obtain a much higher grafting  
density than with the “grafting to” method.  The grafting density that can be achieved with the 
“grafting to” method is limited, due to steric  hindrance and the limited diffusion of the polymer 
chains to the surface during the grafting process.24
The most advanced polymer brushes respond to stimuli such as temperature or pH change. These 
stimuli cause a change in the conformation of the polymer brush.
In a polymer brush there are interactions between the individual polymer chains as well as between 
the  polymer  chains  and  the  solvent-like  attractive  interactions:  van  der  Waals or  H-bond 
interactions, and repulsive interactions: steric hindrance. In a polymer brush, these interactions are 
balanced and define the shape of the brush. If the strength of the interactions changes, for example 
with an increase in temperature, the strength of the H-bond interactions decreases. This will change 
the conformation of the polymer brush.
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1.1.4 Responsive brushes
- Temperature responsive brushes
One example that demonstrates this effect is poly(N-isopropylacrylamide) (PNIPAM) in an aqueous 
solution.  PNIPAM has a lower critical  solution temperature (LCST) of 30 °C. That means that 
above 30 °C the hydrophobic interactions are stronger than the hydrophilic interactions, causing the 
polymer to become insoluble in aqueous solution. With increasing or decreasing temperatures close 
to the LCST ± 5 °C, PNIPAM bound to a surface changes its shape, as was reported by H. Yim et.  
al.25 
- Salt responsive brushes
There are polymer brushes such as  PMAEMA that respond to a high concentration of salt in the 
solvent.  When  adding  salt,  the  electrostatic  interactions  will  change  and  this  will  alter  the 
conformation of the polymer brush, forcing it to collapse.26
- pH responsive brushes
Changing the  pH of  the  solvent  is  another  way to  change  the  structure  of  the  brushes.  Some 
polymers such as poly(acrylic acid) (PAA) are weak acids or bases and they change their ionisation 
state when the pH varies.26 This change influences the interactions between the polymer brush and 
the solvent surrounding the polymer brush. 
When the pH is below the pKa value of the polymer, the polymer is in the collapsed form. When the 
pH is above the pKa value, the polymer is fully stretched. 
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1.2 Self assembly
Amphiphilic block copolymers
AB and ABA block copolymers consist of two different blocks made of different monomers. Block 
copolymers have the ability to form superstructures such as vesicles, micelles or rods. 
In  order  to  form vesicles,  micelles  or  rods,  the polymer  should feature  amphiphilic  properties, 
which result from a combination of hydrophilic and hydrophobic blocks (Figure 1). Hydrophilic 
blocks are readily soluble in polar solvents such as water or methanol and are not soluble in non-po­
lar solvents such as hexane or toluene. Hydrophobic blocks are readily soluble in non-polar solvents 
and are not soluble in polar solvents. In the absence of solvent, block copolymers also form super­
structures such as laminar structures, where they are arranged in layers in order to optimize the in­
teractions between the hydrophobic and the hydrophilic chains. For the formation of ordered super­
structures, three key properties are involved: the overall mass of the polymer (MW), the length ratio 
between the different blocks, and the interaction energy between the monomers in the different 
blocks.27 Diblock copolymers contain one hydrophobic block and one hydrophilic block, while tri­
block copolymers contain one hydrophobic block and two hydrophilic blocks. 
The superstructures (Figure 2) are created by optimizing the hydrophilic and hydrophobic interac­
tions to minimize unfavorable contact between polymer blocks and solvent molecules with different 
polarities.
The driving force behind this optimization is that the system tends toward achieving the lowest en­
ergy level; as a consequence, the process is also driven by a low mixing entropy.28 The formation of 
vesicles, micelles, and rods is similar because all of these morphologies are solvent-dependent self-
assembled superstructures. 
However, micelles strictly lack the shell-like character and encapsulated bulk solution phase of a 
vesicle. Therefore, micelles are not ideal to encapsulate substances. 
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Figure 1.  Schematic representation of amphiphilic copolymers AB (A) and ABA (B)  Copolymers, 
where the hydrophobic block is represented in blue and hydrophilic block in yellow.
Figure 2.  Schematic representation of vesicles prepared from AB (A) and ABA; (B) Copolymers 
where the hydrophobic block is represented in blue and the hydrophilic block in yellow.
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1.3 Nanocarriers
Many substances used in medicine do not remain in the bloodstream for very long. Oral intake of a  
drug is limited by the stability of the substance under proteolytic attack by the environment of the 
body. The encapsulated molecules are protected from the environment of the human body and evade 
the immune system to prolong the in vivo therapeutic half-life of the substrate.
Transportation of a substrate can also be limited, due to insolubility of the substance, which can be 
encapsulated in nanocarriers in order to solve the problem.
Nanocarriers can provide an enhanced dissolution rate of sparingly soluble or hydrophobic drugs 
because  of  their  amphiphilic  structure and  can  be  divided  into  four  main  groups  of  organic 
nanocarriers29: liposomes, micelles, lipidic- or polymer-based micelles or vesicles, and dendrimers. 
Dendrimers30 – tree-like structures formed by the ramification of subunits around a core – are very 
well established for drug delivery. 
Many drug delivery studies have been carried out on lipid vesicles, for reasons of their biocompati­
bility. For this reason, many substances, such as proteins, can be encapsulated in them.
There have been many studies on lipid vesicles in order to mimic Nature. It has been shown that 
lipids are able to form vesicles and can also encapsulate  substances under laboratory conditions. 
The  prepared  lipid  vesicles  can  be  used  as  nanoreactors  or  nanocarriers.  They  provide  high 
biocompatibility  and  close  interaction  with  host  cells.  In  addition,  liposomes  are  capable  of 
delivering both water and oil-soluble compounds,  because of their  amphiphilic  structure. These 
properties have motivated the development of liposomes as drug and protein carriers.
The main drawback to liposomes is that such vesicles have a  short lifespan 35 and a  tendency to 
aggregate or precipitate.36 Their stability can be increased by different methods, including partial 
polymerization, especially the coating of the lipid vesicles with PEG polymers, which increases the 
stability37;  however,  stability  is  not  as  good as  desired.  To further  increase  the  stability of  the 
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vesicles, lipids or lipid conjugates have been replaced by polymers. The use of polymeric vesicles 
constitutes  a  better  approach  because  of  their  increased  mechanical  stability:  block  copolymer 
membranes are thicker  and far more stable than those of liposomes.38 The polymers used have 
molecular  weights  more  typical  of  a  magnitude  of  10  kDa),  whereas  lipids  possess  molecular 
weights less than 1 kDa. Polymeric nanoparticles possess high structural integrity afforded by the 
rigidity of the polymer matrix, and are thus inherently more stable than liposomes. Several different 
kinds of polymers have been used to produce nanocarriers, including poly (ethylene glycol) (PEG) 
and  poly  (lactide  acid)  (PLA) blocks,  poly(butadiene)-poly(ethylene  glycol)  (PEO/PBD)  34 and 
poly(ethylene glycol)-b-(caprolactone) (PEG/PCL). In addition to higher stability, polymers have 
tunable  properties  that  allow  different  applications  due  to  the  differing  compositions  of  the 
hydrophilic and hydrophobic blocks.  These tunable properties include the ability to incorporate 
proteins  into  the  polymeric  membrane,  e.g.  OmpF.42 Important  to  the  functioning  of  many 
nanocarriers is the controlled, sustained release of their cargo. Nanoreactors should be stable in 
order to protect the encapsulated substance until the point where the release of the encapsulated 
substrate should occur. The ability to modify the hydrophobic/hydrophilic blocks for drug targeting, 
with targeting surface functionalization, permits targeted delivery.
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1.4 Nanoreactors
In addition to nanocarriers,  nanoreactors are becoming increasingly important to biological and 
medical  applications,  because they offer  the possibility for  new treatments.  The concept  of  the 
nananoreactor  differs  from  the  concept  of  the  nanocarrier,  in  that  there  is  no  release  of  the 
encapsulated substance in the nanoreactor. The encapsulated substance maintains its functionality 
inside the nanoreactor; therefore, the functionality of the nanoreactor depends on the activity of the 
encapsulated  molecule.  A  nanoreactor  works  as  follows:  molecules  from  outside  enter  the 
nanoreactor via proteins that form tunnels that are incorporated in the copolymer membrane. Such a 
tunnel can be formed e.g. by OmpF. Simple diffusing through the polymer membrane may also 
occur.  The  entering  molecules  react  with  the  molecules  inside  the  nanoreactor.  As  a  result,  a 
modification  or  degradation  of  the  entering  substrate  occurs.  The  requirements  of  a  polymer 
membrane in a nanoreactor are: (i) to allow entrance of a substrate, (ii) high stability,  which is 
required  for  long  lifespan;  (iii)  no  leakage  of  the  encapsulated  substrate,  and  (iv)  high 
biocompability in order not to trigger an immune response. 
1.5 Peroxynitrite degradation
Oxidative stress is related to partial reactive oxygen species (PROS) such as peroxynitrite 1O2, O 2 ·− 
/HOO·, H2O2, HO·, and CO 3 ·−
These species are generated as a side reaction to cell metabolism, or are created by radiation, toxic 
agents, and drugs.45 
Besides ROS, oxidative stress can also be associated with toxicity from a variety of inorganic 
nanoparticles or quantum dots.46-48 Oxidative stress is involved in many diseases and defects. In this 
respect, peroxynitrite has been reported to be implicated in the development of neurodegenerative 
disorders, cardiovascular diseases,51 and cancer.52 There are efficient biological strategies to regulate 
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ROS  to  reduce  or  prevent  the  formation  of  oxidative  stress,  including  cellular  antioxidants 
(glutathione and ascorbate) and enzymes (glutathione peroxidase, glutathione transferases, catalase, 
and superoxide dismutase), but these mechanisms can be overwhelmed by a high quantity of ROS. 
The superoxide anion, which is present in every living cell as a result of normal metabolism53, is 
problematic,  because  it  can  react  with  nitrogen  monoxide,  which  plays  a  critical  role  in  cell 
regulation and communication. If the superoxide anion reacts with nitrogen monoxide, peroxynitrite 
is formed by the diffusion-limited reaction (rate constant ~ 1x1010  M-1 s-1).54 The superoxide anion 
has a short half-life of less than milliseconds55 and permeates membranes only via anion channels.56 
NO is much more stable, having a half-life in the range of seconds, and it readily diffuses across 
membranes57; therefore, peroxynitrite is formed in the area where the superoxide anion is formed. 
The  formation  of  large  quantities  of  peroxynitrite  can  occur  when  a  large  amount  of  O2•– is 
available. Physiological  concentrations  of  peroxynitrite  have  been  reported  on  the  order  of
50 µM 58; however, they have extended as high as 500 µM in some cases.59 This happens when the 
combination of  •NO with  O2•– becomes competitive with the dismutation of O2•– by superoxide 
dismutases, which was shown, for example, in the mitochondrial respiratory complex. Peroxynitrite 
is not only a strong oxidative species, it also has the ability to diffuse longer distances than the 
diameter of a typical cell. For this reason, peroxynitrite can cause damage even far from its origin. It 
has  been  shown  that  amino  acids,  nucleic  acids,  and  membrane  lipids  can  be  modified  with 
peroxynitrites.60 
In order to reduce the amount of peroxynitrite, there are compounds that exhibit high second-order 
rate  constants  with  peroxynitrite.61 In  this  respect,  various  proteins  are  capable  to  detoxify 
peroxynitrite under natural conditions, including peroxiredoxins, Se-containing proteins (glutathion 
peroxidase),  and heme proteins  (hemoglobin,  cytochrome c  oxidase,  FeII cytochrome c),15.  The 
problem is that the concentration of antioxidant enzymes is not high enough to overcome the excess 
peroxynitrite involved in metabolic dysfunction. Administration of the above antioxidant proteins is 
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expected to decrease the amount of peroxynitrite involved in pathological situations. A compound 
that is active in peroxynitrite decomposition and that can be used for medical applications should 
possess several properties: (i) reacting quickly with peroxynitrite; (ii) present in large amounts in 
the desired biological compartment (iii) the decomposition reaction should generate products that 
are  not  toxic  by themselves  and, in  addition,  (iv)  its  reaction with peroxynitrite  should have a 
relatively high rate constant (human hemoglobin has a rate constant of 2x104M-1s-1  at pH = 7.4, at 
37 ºC),64 which supports a medical application.
1.6 Blood substitutes
It  is  well  known that  the hemoglobin (Hb) inside red blood cells  play an essential  role  in  the 
transport of oxygen to organs and tissues. The loss of a large amount of red blood cells can be 
compensated via blood transfusions. Over the course of the last hundred years the demand for blood 
transfusions has steadily increased. Stemming from short storage times 65 and safety risks associated 
with cross-matching and viral infections 66, there have been many attempts to create artificial blood 
with the use of hemoglobin, as will be seen below. 
A limiting factor in the use of hemoglobin in both cases, however, is that, on its own, hemoglobin – 
a tetramer – tends to separate into dimmers . These dimers are rapidly filtered by the kidneys and 
excreted. 69 The use of purely polymeric vesicles, however, can increase lifespan significantly.
One approach to solving both mentioned problems simultaneously is to either polymerize hemoglo­
bin in order to reduce dimerization 70 or to encapsulate it, as occurs naturally in red blood corpus­
cles. The problem with polymerized hemoglobin is that the molecule continues to dissociate 39, thus 
leading to toxic dimers. Therefore, the encapsulation of hemoglobin in a nanocarrier has been at­
tempted. 
In recent years various block co-polymers, including poly (ethylene glycol) (PEG) and poly (lactide 
acid) (PLA) blocks, poly(butadiene)-poly(ethylene glycol) (PEO/PBD)71 and poly(ethylene glycol)-
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b-(caprolactone) (PEG/PCL) have been used to produce nanoobjects such as vesicles that have the 
ability to encapsulate Hb. 
In addition to hemoglobin, other molecules such as perfluorochemicals (PFCs) have been used as a 
potential oxygen carrier. The PFCs have shown promising results in animal tests
The oxygen carrying capacity of PFCs is a function of the high solubility of oxygen and carbon 
dioxide in them (20 times higher than in water). The problem is that PFCs are not water soluble. For 
this reason, PFCs cannot be directly injected into the blood stream and PFCs are used as suspen­
sions with small size droplets of around 0.1 um. In this way, PFCs can be removed from the vascu­
lar space by the reticuloendothelial system and they leave the body through the lungs.72
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2 Materials and methods
2.1 Materials and methods for creating and analyzing the responsive 
polymer brush.
2.1.1 Chemicals
Ascorbic acid, poly(ethylene glycol)methyl ether acrylate (PEOA), 2-hydroxyethyl acrylate (HEA), 
5-bromopyridine-2-thio, (BrC(CH3)2COO(CH2)11 S)2, PMDETA, CuBr and  methemoglobin were 
purchased from Sigma (Switzerland).
2.1.2 SPR 
SPR measurements were performed using a BIAlite system (Biacore, Sweden)  consisting of two 
flow cells. All reagents used in the measurements were dissolved in PBS pH 7.2. The samples were 
degassed before use. The incubation time in the flow cells ranged from 25 to 33 min. The flow rate 
was 3 μl/min. All SPR measurements were performed at 25 °C
2.1.3 1H NMR 
1H NMR spectra were recorded on a Bruker DPX-400 spectrometer operated at  400.140MHzin 
CDCl3 and processed with MestReNova software. Chemical shifts are reported in ppm relative to 
tetramethylsilane. 
2.1.4 QCM 
QCM measurements were performed using a Q-Sense E1 system. The sensors were cleaned using a 
freshly prepared basic Piranha solution (5:1:1 H2O:NH3:H2O2), then rinsed with bidistilled water 
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and afterwards dried under a nitrogen gas stream. The measurements were performed with a flow 
rate of 200 uL/min and 25 °C
2.1.5 ATR-IR 
ATR-IR measurements were acquired using a  Bruker Alpha spectrometer. Spectra were recorded 
with 128 scans and a resolution of 2 cm-1.
2.1.6 ATRP synthesis
Poly(ethylene  glycol)methyl  ether  acrylate,  PMDETA ,  DMF, ascorbic  acid,  and  the  initiator 
5-bromopyridine-2-thiol were added to a Schlenk flask and degassed by argon flow. After stirring 
the mixture at room temperature for 30 min, CuBr was added to start the reaction. The reaction 
proceeded overnight, the polymerization was stopped by opening the flask and exposing the catalyst 
to air. The reaction mixture was then passed through to a neutral aluminum oxide column to remove 
the  copper complex.  The  remaining  unreacted  poly(ethylene  glycol)methyl  ether  acrylate was 
removed by ultrafiltration in H2O, and the pure brush polymer was dried under vacuum.
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2.2 Materials  and methods for creating and analyzing the  polymer 
nanoreactors.
2.2.1 Chemicals
Fluorescent dye Alexa488 carboxylic acid and succinimidyl ester were purchased from Invitrogen 
(Switzerland) and phosphate buffered saline (PBS) (pH 7.2) was obtained from Fluka (Switzerland). 
All chemicals were used without further purification. Outer membrane protein F (OmpF) expression 
was carried out in E. coli (BL21(DE3)omp8)73 according to a previously optimized protocol 74 and 
was stored (700 µg/mL) in 3 wt% OPOE stock solution at 4 °C. The procedure for the synthesis of  
peroxynitrite is described in detail elsewhere.75 
2.2.2 Hemoglobin labeling
A solution  of  1  mg  Alexa488  in  50  µl  DMSO was  slowly  added  to  a  solution  of 15  mg 
methemoglobin in 850 µL PBS buffer. After 15 min 0.1 mL of a 0.1 M Na2CO3 solution was added. 
The mixture was stirred for one hour at  room temperature.  The free dye was removed  by size 
exclusion chromatography (SEC) on Sephadex G25 (300 mm) equilibrated with phosphate buffered 
saline (PBS). The labeling efficiency was determined by UV spectroscopy, using the Beer-Lambert 
law. On average, 2.3 Alexa488 dye molecules per Hb were attached.
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2.2.3 Polymer vesicle and nanoreactor preparation
PMOXA-PDMS-PMOXA  was  synthesized  according  to  the  procedure  described  in.74   The 
copolymer  was  characterized  by  NMR  and  gel  permeation  chromatography  (GPC).  Polymer 
vesicles were prepared by the film rehydration method: 5 mg of triblock copolymer formed a thin 
film on the walls of a 25 mL round-bottom flask using a rotary evaporator. After the addition of 1 
mL PBS  buffer  to  the  polymer  film  and  stirring  for  2  h,  the  solution  was  extruded  through 
polycarbonate  membranes  (pore   =  400  nm)  in  order  to  generate  vesicles  with  a  low  size 
distribution.
The other method that was used was the cosolvent method. In this method the polymer is dissolved 
in a small  amount of ethanol and is  then slowly added while stirring to a buffer solution.  The 
problem with this method is that it  only produced micelles and small vesicles with a radius of  
around 25 nm. The vesicles were too small to encapsulate Hb.
Nanoreactors were prepared by addition of 1 mL of labeled methemoglobin (3 mg/mL in PBS 
buffer) to the polymer film, stirring for 2 h, and extrusion through polycarbonate membranes (pore 
 = 400 nm). Vesicles containing both the protein, and the channel protein OmpF were prepared by 
simultaneous addition to the polymer film of: 0.95 mL of metHb (3.16 mg/mL in PBS buffer), and 
50 µL of OmpF (8 µM  in PBS buffer),74 stirring for 2 h,  and extrusion through polycarbonate 
membranes (pore  = 400 nm). Hb initial concentration was selected such that a similar value was 
achieved as in the case of other Hb-encapsulated vesicles.76 The extrusion process results in a loss 
of around 50% of the polymer-hemoglobin aggregates, which has been taken into account for the 
encapsulation efficiency of Hb. In order to purify the un-encapsulated methemoglobin, the extruded 
mixture was dialyzed with 300 kDa molecular weight cut off dialysis bags in PBS at 2 – 3 °C at a 
1:300 v/v, the dialyzed sample to PBS ratio. In addition, the solution was purified by size exclusion 
chromatography (SEC) on a Sephadex G25 column (300 mm) equilibrated with PBS. The final 
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solution was analyzed by FCS to determine the fraction of encapsulated hemoglobin.
2.2.4 Characterization of polymer vesicles and nanoreactors
2.2.4.1 Light Scattering 
Light  Scattering  (LS)  experiments  were  performed  with  a  compact  goniometer  system 
ALV/DS/SLS 5000/E correlator, from ALV, Langen (Germany), equipped with a helium-neon laser 
(JDS Uniphase) with  = 633 nm (T = 20 °C). The diffusion coefficient (D0) was obtained from a 
second-order  fit  of  dynamic  light  scattering  (DLS) data  from dilute  suspensions.  From  D0,  the 
hydrodynamic radius (Rh) was calculated using the Stokes- Einstein relation. Scattering angles were 
varied  between 30°  and 150°,  with each 10 angles  measured  for  100 seconds.  For  static  light  
scattering  (SLS)  measurements,  the  data,  presented  in  a  Guinier  plot  extrapolated  to  zero 
concentration and zero scattering angle, were used to calculate the radius of gyration.77
2.2.4.2 Transmission Electron Microscopy 
Transmission Electron  Microscopy (TEM)  micrographs were recorded using  a  CM 100 Philips 
microscope operating at 120 kV, and equipped with an USC1000-SSCCD 2 k_2 k Gatan camera. 
The solution of vesicles (empty vesicles, and Hb-containing vesicles) was deposited on a carbon-
coated copper grid. The excess solution was removed using absorbent paper and the sample was 
allowed to dry at room temperature for 1 min before the images were recorded. The grids were 
stained with uranyl acetate.
2.2.4.3 Hemoglobin encapsulation efficiency
The  encapsulation  efficiency  and  the  percentage  of  free  Hb  were  measured  by  fluorescence 
correlation spectroscopy (FCS).  Solutions of Alexa Fluor 488, Alexa Fluor 488-methemoglobin, 
and  Alexa  Fluor  488-metheoglobin-containing  vesicles  were  measured  at  room temperature  in 
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special  chambered  quartz-glass  holders  (Lab-Tek;  8-well,  NUNC  A/S)  that  provided  optimal 
conditions  for  the  measurement  while  reducing  evaporation  of  the  aqueous  solutions.  FCS 
measurements were performed with a Zeiss LSM 510-META/Confocor2 confocal laser scanning 
microscope (Zeiss AG, Germany) equipped with an argon laser ( = 488 nm) and a 40x water-
immersion objective (Zeiss C/Apochromat 40X, NA 1.2), with the pinhole adjusted to a diameter of 
70 µm. The excitation power of the Ar laser was PL = 40 mW, and the excitation transmission at 488 
nm was 3%.  Fluorescence  intensity  fluctuations  were  analyzed  in  terms  of  an  autocorrelation 
function with the LSM 510/Confocor software package (Zeiss, AG).  Spectra were recorded over 
30 s, and each measurement was repeated ten times; results are reported as the average of three 
independent experiments. Adsorption and bleaching effects were reduced by exchanging the sample 
droplet  after  5  minutes  of  measurement.  To  reduce  the  number  of  free  fitting  parameters,  the 
diffusion time  of  the  free  dye  (Alexa  Fluor  488),  and  of  Alexa  488-labeled  methemoglobin 
(Alexa488-metHb) were independently determined and fixed in the fitting procedure.
2.2.5 Activity assays for peroxynitrite degradation and oxygen binding of Hb
The conversion  of  Hb was  similarly  established in  solution and  in  situ inside  nanoreactors  by 
various reactions: 
a) Conversion of metHb was realized by:
i. addition of L-ascorbic acid and carbon monoxide, and
ii. addition of sodium dithionite.
i) A solution of 2 μmol methemoglobin in 1 mL PBS was converted by adding 50 L of L-ascorbic 
acid solution (1 mol/L in PBS). After reacting for 10 min, the mixture was flushed with carbon 
monoxide for 10 min.
ii) Methemoglobin (900 L of 50 M metHb solution) was converted by adding 100 L of sodium 
dithionite  solution  (10  mmol/L  in  PBS)  at  room  temperature.  Excess  sodium  dithionite  was 
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removed  by  SEC.  The  SEC  column  consisted  of  Sephadex  G25  (300  mm)  equilibrated  with 
phosphate buffered saline (PBS).  Samples were measured both before and after removal of the 
sodium dithionite excess.
b)  Peroxynitrite  degradation was  achieved by the addition of  100  L of 10 mM peroxynitrite 
solution to 900 L of a 50 µM HbO2 or deoxyHb solution (pH 7.4, room temperature). At least 8 – 
10 mol ONOO- were required to completely convert 1 mol of HbO2 to metHb. 
c) Oxygen binding was tested by conversion of deoxyHb to HbO2 and by conversion of HbO2 to 
HbCO. DeoxyHb obtained after  addition of sodium dithionite was passed through a column of 
Sephadex G25 (100 mm) to remove the excess  sodium dithionite, in the presence of oxygen. To 
obtain HbCO, an HbO2 solution was flushed with carbon monoxide for 20 min.
The different oxidation states of hemoglobin were measured by UV-Vis spectroscopy and Raman 
spectroscopy. UV-Vis measurements were performed at room temperature using a SPECORD 210 
Spectrophotometer (Analytic Jena, Germany). The spectra were recorded at room temperature, in a 
range from 390 nm to 1000 nm. Samples were measured immediately after preparation (within 20 
s), to avoid further reaction with nitrate, a ubiquitous contaminant of ONOO- solution.
2.2.6 Raman spectroscopic characterization:
Raman spectra were recorded using an alpha300R (WITec GmbH, Ulm, Germany) confocal upright 
microscope spectrometer (UHTS 300, WITec) equipped with epi-illumination. A water immersion 
objective lens with glass correction (Olympus UAPON 40XW340 NA1.15WD0.25UV) was used to 
focus the laser beam on the sample and to collect the Raman backscattered light. Raman scattering 
was excited by a 532 nm Nd:Yag laser.  Sample preparation for Raman experiments: Hemoglobin 
samples were analyzed between two 0.15 mm thick glass cover slides separated by a 50 µm thick 
double  sided  tape  (Tesa,  Switzerland).  All  measurements  were  performed  with  the  laser  beam 
focused  20  µm  below  the  top  cover  slide.  The  Raman  signal  could  not  be  collected  from 
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encapsulated hemoglobin solutions because the Rayleigh scattering from the 200 nm-size vesicles 
interfered greatly with spectra acquisition. Moreover, the encapsulated Hb concentration in solution 
was  one  order  of  magnitude  lower  than  what  would  normally  be  detected  using  Raman 
spectroscopy. We thus decided to work at a bulk concentration between 20 and 50 µM, which is 
relevant to a local protein concentration within one vesicle when considering between 10 and 20 
encapsulated  protein  molecules  per  polymeric  vesicle. Each  Raman  spectrum  represented  the 
cumulative signal of 100 measurements of 1 s integration time. Spectra were processed to remove 
cosmic  rays  (WITec  Project  Software)  and  background  corrected  by  subtraction  of  the  signal 
acquired with the laser off immediately after each series of 100 consecutive measurements. 
2.2.7 Stopped flow spectroscopy
The kinetics of the reaction of hemoglobin with peroxynitrite was studied by  single-wavelength 
stopped flow spectroscopy under pseudo-first order conditions (at  = 430 nm). Peroxynitrite was 
always present at least at 10-fold excess, to maintain pseudo first order conditions. Measurements 
were performed at  room temperature using an SFM-20 instrument  equipped with an MOS-200 
monochromator. The degradation of peroxynitrite was measured at its absorption maximum  = 302 
nm. The traces  correspond to the average of at  least  10 single traces,  and were analyzed with 
Biokine32 software. The data were fitted with a second order exponential fit. In order to acquire a 
better signal, the nanoreactor solution was concentrated by centrifugation (10 min at 4500 rpm).
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3 Results and discussion 
3.1 Responsive polymer brush
In material  science,  polymer brushes  are  important  for  the protection of  surfaces.  Brushes can 
prevent fouling of the surfaces because they hinder the binding of other molecules to the surface.
Another  application  for  polymer  brushes  that  was  investigated  in  this  study  was  the  use  of 
responsive brushes to create a selective layer that combines passivation abilities with the supply of 
binding sites for special molecules. This selectivity of binding lends the brush the ability to detect 
specific molecules. In these studies we used a polymer with PEG side chains to create the polymer 
brush. We also used special, commercially available antibodies that are able to bind to the PEG 
chains (Figure 3). 
Figure 3. Schematic representation of the antibodies bound to the polymer brush.
3.1.1 PEG 
PEG has been used for different applications, due to its renowned properties of biocompatibility and 
protein  resistance.78 PEG polymers  have  a  high  capacity to  passivate  a  surface.  This  has  been 
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demonstrated for different applications of anti-fouling surface protection, such as protection from 
protein-  and cell  adsorption  on  various  kinds  of  surfaces78,  and  it  is  also  used  as  a  part  of  a 
copolymer for the protection of ultrafiltration membranes used in water purification.79 It can also be 
used in biomedical applications80 to reduce immunogenicity and to shield drugs, prolonging their 
circulation  time  in  the  blood  stream.  PEG  reduces  the  tendency  to  aggregate  and  increases 
resistance to proteolytic cleavage in drug targeting.80
3.1.2 PEG-binding
In this study, PEG-specific antibodies have been used as a model protein for the selective binding of 
molecules  to  the surface  and have also  been developed for  the  measurement  of  PEG-modified 
molecules in vivo, for drug development. These antibodies have the ability to bind to repeating units 
of PEG. (Figure 4).
that passivate the surface; therefore, PEG chains have a dual-function of surface passivation and 
providing binding sites for the antibodies. Another advantage is that antibodies are huge proteins 
and therefore the extent of binding of the antibodies shows the degree to which binding sites are  
accessible for large molecules.
Figure 4. Polymer with antibody binding sites.
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3.1.3 Initiator
The initiator is important because, in addition to the bromide that is required for the polymerization, 
the initiator also provides the thiol group for “grafting to” the surface. The first used ATRP initiator 
was (BrC(CH3)2COO(CH2)11 S)2  This initiator was not used for further experiments. The problem 
with this initiator was that the polymerization only leads to oligomers. As a result, therefore, the 
number of repeating units of PEG chains was very low. The initiator is symmetrical and contains 
two bromides that can form two radicals and is therefore able to react intermolecularly to form a 
ring. For this reason, 5-bromopyridine-2-thiol was used as the initiator. The new initiator only forms 
one radical, so it cannot react intermolecularly, but it has low activity and, for this reason, only a 
small fraction of the monomer polymerizes. The GPC data show that he polymer only consisted of  
around 20 repeating units.
3.1.4 PEGA Polymer
We selected for testing a polyPEGA polymer with a branched architecture. Instead of a linear PEG 
homopolymer,  in order to introduce specific binding sites for future functionalizations, knowing 
that  the  polymer  brush  has  the  same  passivation  abilities  no  matter  of  formed  from linear  or 
branched  polymers  (Figure  5).  The  PEGA polymer  with  desired  branched  architecture  was 
synthesized by the controlled radical polymerization of poly(ethylene glycol)methyl ether acrylate 
(PEGA) monomers.
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Figure 5. Structure of the branched polymer.
The monomer that was used for the polymerization was a poly(ethylene) glycol acrylate with 8 – 9 
repeating units of PEG. This number of repeating PEG units is needed in order to provide a binding 
site for the antibody. Another problem is that the polymer has a carbon backbone that can lead to 
highly unspecific binding. The  carbon backbone is hydrophobic; therefore, unspecific binding of 
other hydrophobic molecules can occur. The PEG chains that were used are long enough to shield 
the carbon backbone and prevent  the unspecific  binding.  Polymer formation was confirmed by 
1H NMR (Figure 6). The GPC measurements showed that the polymer has an average Mn of 12000 
and a PDI of 1.3, in average polyPEGA contained 20 repeating units of poly(ethylene glycol)methyl 
ether acrylate (PEGA) monomer (Figure 9).
Other monomers with different numbers of PEG repeating units were tested, for example polymers 
with shorter side chains with only three PEG repeating units are not adequately water soluble and 
they can only be dissolved in water at low temperature, while polymers with longer side chains with 
18  to  20  repeating  units  can  be  prepared,  but  the  polydispersity  is  higher  (Figure  7).  The 
poly(ethylene  glycol)methyl  ether  acrylate  (PEGA) monomers  were  also  copolymerized  with 
2-hydroxyethyl acrylate (HEA) monomers (Figure 8). The addition of shorter chains may increase 
the binding of antibodies, because they provide more space for the antibodies to bind. The problem 
with these copolymers is that they form hydrogels.  The copolymerisation is important in order to 
create a polymer brush that is not specifically prepared for binding  PEG-binding antibodies, but 
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also for binding other molecules. Such as tris-nitrilotriacetic acid  that provides binding sites for 
other molecules.
The  PEG  monomer  can  be  copolymerized  with  other  molecules  that  contain  an  acrylate  or 
methacrylate group that contains binding sites for other molecules. The copolymers may provide 
binding sites for other molecules and maintain their surface passivation abilities and, as a result, 
many different monomers can be used, because PEG is soluble in many different solvents. In order 
to attach the polymer to the surface and create a polymer brush,  the polymer should contain a 
terminal thiol group that can be attached to a gold surface. 
Figure 7. 1H NMR spectrum of the poly(ethylene glycol) methyl ether acrylate polymer with 8 – 9 
repeating units of ethylene glycol .
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Figure 7. 1H NMR spectrum of the poly(ethylene glycol) methyl ether acrylate polymer with 18 – 
20 repeating units of ethylene glycol.
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Figure 8. 1H NMR spectrum of the copolymer of poly(ethylene glycol) methyl ether acrylates and 
poly-2-hydroxyethyl acrylate.
Figure 9. GPC spectra of the poly(ethylene glycol) methyl ether acrylate polymer with 8 – 9 repeat­
ing units of ethylene glycol.
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3.1.5 ARGET ATRP
The method used for  the  polymerization of  poly(ethylene glycol)methyl  ether  acrylate  (PEOA) 
monomers was atom transfer radical polymerization ARGET ATRP (Scheme 1). This method is one 
of the most successfully controlled/living radical polymerizations (CRP),83 due to its robust nature 
and to the possibility of controlling  molecular weight and providing a narrow molecular weight 
distribution  Mw/Mn,  <  1.5. It enables synthesis of a wide spectrum of polymers and allows the 
controlled synthesis of polymers with a branched structure with different chains, leading to different 
architectures  such  as  block-,  random-,  gradient-,  comb-shaped-,  brush-,  multiarmed-,  end-
functional-, and star copolymers, increasing in this way the number of multiple applications. 
In addition to the wide variety of monomers that can be polymerized with ATRP it is also possible 
to use a wide variety of non-organic and organic solvents.90 ATRP has been successfully used for the 
polymerization of PEG-containing copolymers91-93
Scheme 1. Polymerization reaction of the monomers.
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3.1.6 Polymer Brush 
The brushes were formed on a gold surface (Figure 9). A gold surface was used because it can bind 
strongly to thiols and disulfides. The polymer brush can be produced with two different methods: 
the “grafting from” and the “grafting to” method. The method that was used was the “grafting to” 
method because it allows the synthesis of the polymer in solution and the final polymer can then be 
easily grafted onto the surface by simply deposition. The “grafting from” method was not used be­
cause it is more complicated, due to the polymerization all being done on the surface. The advan­
tage of the “grafting from” method is that it allows a higher density of the polymer brush. The ex­
periments have shown that the grafting density with the “grafting to” method is high enough. The 
brush density is an important point when it comes to the surface passivation and the binding of the 
PEG-binding antibodies. The surface has to be covered with a brush that is dense enough so that no 
other molecule can bind to the surface. For the binding of the antibodies on the other side, a low 
grafting density is favorable because the  antibodies need space to bind to the binding sites of the 
polymer. The polymer that was used has a different structure than other polymers that have previ­
ously been grafted on the surface. The influence of the different structure also has an influence on 
the brush formation. 
In order to confirm that deposition of the polymer on the surface, the sample was analyzed with at­
tenuated total reflection infrared spectroscopy (ATR-IR), a blank gold slide was measured as a ref­
erence, for which no adsorption bands could be detected. The spectra of the polymer monolayers on 
gold were recorded. ATR-IR measurements can yield information on the structure of the polymer 
that is attached to the surface. The ATR-IR measurements confirmed that the polymer is attached to 
the surface. The peak at 1117 cm-1 shows the ether bonds of the PEG side chains and the bonds at 
1570 cm-1 show the ester group (Figure 10).
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Figure 10. ATR-IR spectra of the polymer brush-coated gold surface with the bonds from the ester 
group at 1570 cm-1 and ether bonds at 1117 cm-1
The  monolayer  formation  was  also  characterized  by  surface  plasmon  resonance  spectroscopy 
(SPR). This optical method allows for non-invasive thin film characterization and is very sensitive 
to small changes in adsorbed mass.  In order to form a polymer brush on the surface, the polymer 
was dissolved in PBS buffer and then deposited on the gold surface. After washing, a film remained 
on the surface. The same procedure was repeated and the amount that was deposited after the sec­
ond cycle was low. This showed that the surface was already covered with the polymer film. No fur­
ther polymer was able to attach to the surface (Figure 11). The thickness of the polymer brush was 
calculated to be 10.2 nm ± 2.5 nm. In a second step, BSA was added to the polymer film. BSA is a 
protein  with  high,  unspecific  binding and it  attaches  to  nearly any surface.  The measurements 
showed that BSA was not able to attach to the surface. All of the deposited BSA on the surface was 
removed by flushing the surface with buffer (Figure 12). This result showed that the BSA cannot 
attach to a polymer coated surface. From this, we conclude that the polymer brush has high passiva­
tion ability. The passivation indicates that there is no free surface to which the BSA can bind.
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Figure 11. SPR spectrum of the adsorption of the polymer to a gold surface. The polymer solution 
was deposited on the sensor (B), which changes the frequency compared to the baseline (A). Then, 
the polymer was able to graft onto the surface for 5 min. The sensors were then flushed again with 
water to remove the free polymer that could not graft to the surface (C). In a second step the poly­
mer solution was added again to the sensor, then the polymer was able to graft onto the surface for 
another 30 min (D). The sensors were then flushed again with water to remove the free polymer that 
was not attached to the surface (E). 
Figure 12. BSA adsorption to a polymer-coated gold surface
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A commercially available PEG 20k was used as a reference to compare brush formation. It has been 
reported  that  PEG  20k  is  able  to  passivate  a  gold  surface  and  it  is  also  able  to  bind  PEG 
antibodies.94 PEG 20k is known to form dense brushes on the surface. Our polymer showed similar 
results to PEG 20k. The antibodies were placed on the polymer coated surface. The PEG side chains 
provide  binding  points  for  the  antibody  surface.  With  SPR,  an  antibody  binding  curve  was 
observed. The SPR data shows that the antibodies can bind to the polymer coated surface (Figure 
13). The equilibrium dissociation constant KD of the antibody binding was calculated by fitting Req 
to the Langmuir adsorption isotherm95 giving KD = 0.77 ± 0.93 nM (Figure 14). The calculation 
does not provide good results because the amount of data from the antibody binding curve that 
could be used was small.
Figure 13. Antipeg binding curve for a polymer-coated surface.
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Figure 14. Antipeg binding curve fitted to the Langmuir adsorption isotherm.
In addition to the SPR measurements, QCM measurements have also been done to analyze brush 
formation and surface passivation. QCM measures mass per unit area by detecting the change in 
frequency of a quartz crystal resonator. The resonance is disturbed by the addition of molecules that 
bind to the surface. As a mass is deposited on the surface of the crystal, the thickness increases and 
the  frequency  of  oscillation  decreases  from  the  initial  value.  This  frequency  change  can  be 
quantified and correlated to the mass change using Sauerbrey's equation.96 In this experiment, a 
sensor with a gold surface was used. The polymer was dissolved in water at a concentration of 1  
mg/mL and deposited on the sensor. 
The polymer was then able to graft onto the surface for 30 min. The sensors were than flushed again 
with  water  to  remove  the  free  polymer  that  wasn’t  grafted  to  the  surface.  The  change  in  the 
frequency  shows  the  amount  of  polymer  that  was  attached  to  the  surface.  By comparing  the 
frequencies before the addition of the polymer solution and after the flushing of the sensor with 
water, the mass that was attached to the surface can be obtained. The change in mass on the sensor 
shows that a brush with a thickness of 6.2 nm ± 2.5nm was created. The QCM measurements show 
that the polymer was bound to the surface. In a second step, BSA was added to the polymer film.  
The measurements showed that BSA was not able to attach to the surface. All of the deposited BSA 
on the surface was removed by flushing the surface with water (Figure 15) 
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Figure 15. QCM spectra of the adsorption of the polymer and BSA to the gold surface. The poly­
mer solution was deposited on the sensor (B), which changed its frequency compared with the base­
line (A). The polymer was then able to graft  to the surface for 30 min.  The sensors were then 
flushed again with water to remove the free polymer that wasn’t grafted to the surface (C). The BSA 
solution was deposited on the polymer coated sensor (D). 
Then, the BSA was able to graft onto the surface for 30 min. The sensors were then flushed again  
with water to remove the free BSA that wasn’t attached to the surface (E).
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3.1.7 Conclusion: Polymer brush
Here, we have synthesized and characterized a responsive  polymer brush with dual-functionality: 
surface passivation and with selective binding sites for specific molecules. We selected a polymer 
with branched architecture because of its ability for further modification and copolymerization. The 
polymer was successfully synthesized by ARGET ATRP. The polymer structure was confirmed by 
1HNMR. The GPC measurements showed that the polymer on average has 20 repeating units of the 
poly(ethylene  glycol)methyl  ether  acrylate  (PEGA)  monomer.  The  polymer  was  able  to  be 
deposited on the surface via the grafting to method, while the QCM and SPR measurements showed 
that a 6.2 – 10.2 nm thick polymer brush was deposited on the gold surface.
The  polymer  has  been  shown to  be  efficient  at  passivation.  Surface  passivation  abilities  were 
proven by SPR and QCM. In addition to the passivation, the system also provides many possible 
binding sites. An antibody binding curve was recorded by SPR, indicating clearly that the antibody 
was able to bind to the polymer brush. This new system was able to achieve higher selectivity, 
which means low unspecific binding and high specific binding.
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3.2 Hemoglobin nanoreactors 
The aim of the project was to generate a nanoreactor with the dual functionality of oxygen transport 
and peroxynitrite reduction. Therefore, a substance that had the ability to transport oxygen and to 
degrade peroxynitrite was needed. Hb was used as a model protein because Hb has the ability to 
transport oxygen and reduce peroxynitrite. The advantage of Hb is that it is commercially available, 
has a good stability, and its activity can be detected by UV- absorption measurements. That allows 
the study of the protein inside the nanoreactor.
3.2.1 Polymers used for nanoreactor preparation
All  nanoreactors  used for this  study were obtained from PMOXA-b-PDMS-b-PMOXA triblock 
copolymer  self-assembly  (Figure 16).  PMOXA-b-PDMS-b-PMOXA triblock  copolymers  were 
previously reported in the literature as suitable for drug delivery, due to their increased stability and 
non-toxicity. The triblock copolymer nanoreactors were proven to be impermeable to hydrophilic 
cargo99 and prevented it from leaking into in the reaction medium.100 With a proven record of good 
biocompatibility,101 the  membrane  of  PMOXA-b-PDMS-b-PMOXA  nanoreactors  possess  high 
flexibility that allows for the insertion of channel proteins, such as OmpF, LamB, or Aquaporin Z 
without affecting their proper functionality. The incorporation of channel proteins within the vesicle 
membrane  is  essential  to  allow  substances/products  to  penetrate  through  and  support  the 
nanoreactor functions.  The chemical structure of the polymer used for preparing the nanoreactors 
has a major influence on both the shape and size of the nanoeactors and their ability to encapsulate 
molecules. For encapsulation of hemoglobin, nanoreactors with a radius of 100 nm were preferred. 
It is important that the polymer forms nanoreactors in higher numbers, high enough to encapsulate a 
reasonable amount of Hb molecules. The nanoreactors were formed by copolymer self-assembly in 
phosphate buffer.  For the formation of nanoobjects with defined shapes such as micelles,  rods, 
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vesicles  or  aggregates,  the  ratio  between  the  length  of  the  hydrophilic  and  the  lengths  of  the 
hydrophobic blocks is crucial. The selection of a specific ratio defines the shape of the nanoobjects 
and their sizes. In order to determine the optimal ratio for vesicle formation, different PMOXA-b-
PDMS-b-PMOXA copolymers with various ratios of hydrophilic to hydrophobic segments were 
tested. In addition to their ability to form vesicles, the polymer also has to fulfill other requirements. 
It  is  important  that  the  polymer  not  interact  with  the  molecules  that  will  be  encapsulated.  An 
interaction of the polymer with the guest might interrupt vesicle formation. This kind of interaction 
usually occurs if the polymer and the substances are charged. As encapsulated molecules can be pH 
dependent, the encapsulation will work best at specific pH values.76 The stability of the vesicles is 
important, because a nanoreactor is designed to circulate in the bloodstream for a long time. This is 
why it is crucial that the polymer form mainly vesicles and less so aggregates or rods. The polymer 
has to form nanoreactors with low size polydispersity. Several experiments have been conducted in 
order to decide which polymer to use for further experiments. All vesicle solutions obtained from 
the different  PMOXA-b-PDMS-b-PMOXA copolymers were analyzed by TEM and FCS.  TEM 
measurements give an overall image that shows whether a polymer forms vesicles, micelles, rods or 
aggregates,  and  also  provides  information  about  their  size.  In  FCS,  only  nanoobjects  that 
encapsulate fluorescent active molecules can be seen. Those nanoobjects, such as micelles or rods, 
that do not encapsulate fluorescent active molecules cannot be detected by FCS. FCS measurements 
indicate  whether  the  produced nanoobjects can  encapsulate  Hb.  These  methods  were  used  to 
analyze  the vesicle  solution  formed by the  different  polymers  and to  choose the  most  suitable 
polymer. More detailed analyses were carried out with the chosen polymer.
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Figure 16. Chemical structure of  PMOXA-b-PDMS-b-PMOXA consisting of the two hydrophilic 
PMOXA and one hydrophobic PDMS block. 1H NMR spectra of the PMOXA-b-PDMS-b-PMOXA 
copolymer.
The shape and size distribution of polymer nanoreactors can be designed by choosing the optimal 
ratio of PMOXA to PDMs blocks. So even though the tested polymers only differ from the point of 
view of their  lengths  of the hydrophobic and hydrophilic  blocks,  their  outcomes differ  greatly. 
Every polymer has a specific tendency to form rods, micelles, vesicles or aggregates. This affects 
the encapsulation efficiency, because micelles or rods are not able to incorporate Hb.
The first polymer that was tested was an A10B87A10 triblock copolymer. The vesicles were prepared 
using  film rehydration.  After  the preparation  and purification  steps  the polymer solutions  were 
analyzed with TEM (Figure 17) and FCS. From the FCS measurements, information on the size of 
the vesicles and the encapsulation efficiency were obtained. The TEM images provided information 
on the shape and size of vesicles, micelles, rods or other aggregates. For the proper function of the  
nanoreactors,  it  is  important  to  have  a  vesicle  solution  with  specific,  narrow size  distribution, 
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because  only  vesicles  with  a  certain  diameter  of  a  minimum  of  50  nm have  been  shown  to 
encapsulate hemoglobin. Because they are too small, micelles are not suitable for the encapsulation 
of hemoglobin and hence they reduce the encapsulation efficiency. For A10B87A10  copolymers, the 
obtained vesicle solution was not homogeneous, but contained fractions of vesicles, rods, micelles 
and aggregates. Only the vesicles fraction was able to incorporate labeled Hb, as the FCS data 
confirmed, while the fractions of micelles and rods formed do not encapsulate Hb.
This polymer could not be used further for the preparation of nanoreactors because of the high 
percentage of aggregates that were formed. The aggregates consist of small vesicles or micelles that 
stick together to form bigger structures. Aggregate formation can be caused by interactions between 
the polymers or polymer with hemoglobin. Therefore, it is difficult to analyze whether labeled Hb 
was successfully encapsulated into the polymer vesicles.
Figure 17. TEM images from the A10B87A10 copolymer showing vesicles, micelles and rods.
A second polymer tested was an A12B55A12 block copolymer. This was the first polymer that showed 
promise for nanoreactor preparation. TEM pictures indicated that mainly vesicles were formed by 
A12B55A12 self-assembly (Figure 18). The advantage of this polymer compared with those previous 
tested is that it  did not form large aggregates and the formed vesicles were able to incorporate 
hemoglobin. In addition to the vesicles, the polymer also formed micelles and rods. Despite the 
formation of micelles and rods, the main reason why this polymer was not used for further studies 
41
was that there was not enough polymer to proceed with the project.
Figure 18. TEM images from the A12B55A12 copolymer showing vesicles and micelles.
The polymer tested finally was an A6B90A6 block copolymer. The polymer consists of two blocks of 
six repeating units of PMOXA and 90 repeating units of PDMS. The TEM images of the A6B90A6 
copolymer showed the most promising results (Figure 19). The copolymer has a large hydrophobic 
block compared to the hydrophilic block. This polymer forms mainly vesicles and some micelles. 
No rods or aggregates were formed. The solution contained a good amount of vesicles that were 
large enough to encapsulate a reasonable amount of hemoglobin.  The vesicles were larger than 
those generated by the other polymers. Although all of the polymers used were able to incorporate 
some quantity of Hb, some polymers,  such as the A10B87A10,  could not  be used because of the 
formation of large aggregates. The PMOXA6-PDMS90-PMOXA6 polymer has been shown to form a 
narrow size distribution population in solution. Because of its ability to form mainly vesicles, this 
polymer  was  chosen  for  further  research. In  addition  to  the  composition  of  the  polymer,  the 
preparation method also has great influence on the formation of vesicles. For the chosen polymer,  
the vesicles were prepared using two different methods. The first was the film rehydration method. 
For this, 5 mg of triblock copolymer were dissolved in ethanol and the solution was then evaporated 
under reduced pressure. The polymer formed a thin film on the walls of a 25 ml round-bottom flask 
using a rotary evaporator. After the addition of 1 ml PBS buffer to the polymer film and stirring for 
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2 h, the solution was extruded through polycarbonate membranes (pore diameter = 400 nm) in order 
to generate vesicles with low size distribution. During the extrusion, the non-dissolved polymer was 
also removed. Both empty vesicles and protein-containing vesicles were prepared under similar 
conditions using 5 mg of polymer and PBS buffer. The vesicles were analysed by light scattering 
(dynamic  light  scattering,  DLS,  and  static  light  scattering,  SLS)  and  transmission  electron 
microscopy, TEM. The other method that was used was the co-solvent method. In this method the 
polymer was dissolved in a small amount of ethanol and then it was added slowly into a buffer  
solution while stirring. The advantage of this approach is that it  provides a more homogeneous 
vesicle solution than the film rehydration method, while nearly 100% of the polymer used forms 
vesicles or micelles. The problem with this method was that it only produced micelles and small 
vesicles with a radius of around 25 nm (Figure 20). The vesicles were thus too small to encapsulate 
Hb. This method was not used for any further experiments. 
Not only does the method used have a great influence on the vesicle formation, but the conditions 
(temperature, stirring time and stirring intensity) during vesicle formation has a great influence on 
the final result. The different polymers behave differently and their ideal conditions depend strongly 
on their hydrophilic hydrophobic block ratio. Therefore, vesicle formation was performed under 
several  different  conditions  in  order  to  find  the  most  suitable  one  for  the  requirements  of  the 
nanoreactors. For most of the polymers, a long stirring time of more than 8 h was optimal because 
this gave the polymer more time to self- assemble in order to form vesicles. However, extended 
stirring time is not always preferable because of the mechanical force that is applied during the 
stirring  process.  Therefore,  a  long  stirring  time  is  not  ideal  if  the  copolymer  has  a  high 
hydrophobicity. The polymer used has both a high hydrophobicity and a tendency to clump together 
and precipitate after extended stirring. The ideal condition for nanoreactor formation was a stirring 
time of around 2 h at room temperature. One disadvantage of the short stirring time is that only 50% 
of the polymer forms vesicles or micelles, the rest of the polymer stays on the polymer film on the 
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bottom of the flask.
Figure 19. TEM images of A6B90A6 copolymer of empty vesicles (A), and vesicles with encapsu­
lated metHb (B). Scale bar = 200 nm. 
Figure  20. TEM  images  of  A6B90A6 copolymer micelles  that  are  produced  by  the  co-solvent 
method. 
The  A6B90A6 copolymer  behavior  in  solution  was  studied  in  more  detail  with  DLS/SLS.  The 
measurements were necessary because they provided additional data to characterize nanoreactors in 
solution. 
Static Light Scattering (SLS).  SLS is a technique that uses the intensities of scattered light at a 
number of angles to derive information on the nanoobjects in the solution. From light scattering, 
data on the radius of gyration Rg and the second virial coefficient A2 can be derived (Figure 21). 
104-107
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Figure 21.Second order fits of SLS data in a Guinier plot of nanoreactors (A) and empty vesicles 
(B).
Dynamic Light Scattering (DLS).  Dynamic light scattering uses the  concept of small particles 
moving randomly in solution. Fluctuations in the scattering arise from the fact that small molecules 
in solution undergo Brownian motion. Brownian motion causes a change in the distance between 
the scattering objects  in the solution. The change in the distance leads to either constructive or 
destructive interference by the surrounding particles. The information on the nanoobjects is derived 
from an autocorrelation function of the intensity trace recorded during the experiment (Figure 22).
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Figure 22.Second order fits of DLS by nanoreactors (A) and empty vesicles (B).
The analysis of the samples by DLS and SLS indicates the presence of two different populations of 
nanoobjects: a small fraction of spherical objects with a hydrodynamic radius (RH) of around 45 nm, 
and a larger fraction of spherical objects with a hydrodynamic radius of RH= 164 ± 15.4 nm. The 
small  RH of around 45 nm of the first fraction indicates micelles.  The light scattering from the 
micelles  fraction  was  not  as  dominant,  and  the  influence  of  the  scattering  was  therefore  not 
significant. The majority of the scattering occurs from the fraction with the larger  RH of 164 nm. 
The analysis of the samples by SLS showed that the fraction of the larger spherical objects has a 
radius of gyration Rg of 194  ± 8.2 nm. In order to analyze whether this population consists of 
vesicles, the ratios of the hydrodynamic radius RH and the radius of gyration Rg were compared as 
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RH/Rg = 0.84. A value of 0.84 indicates that the major population consists of spherical vesicles. In 
order to analyze whether the encapsulation of metHb has an influence on vesicle formation, the 
DLS and SLS data of empty vesicles and vesicles that contain metHb were compared. A comparison 
of the DLS data shows that the presence of metHb does not influence vesicle formation. Therefore,  
there is no interaction between the polymer and the metHb. The samples were also analyzed by 
Transmission Electron Microscopy, TEM. The TEM micrographs indicate the presence of circular 
objects with a mean radius of around 28 ± 8.5 nm and spherical objects with a mean radius of 120 ± 
20 nm. From the small radius of 28 ± 8.5 nm of the first fraction, we assume them to be micelles.  
The fraction of spherical objects with a mean radius of 120 ± 20 nm was expected to be vesicles. 
The higher value RH obtained by LS experiments as compared to the size of the vesicles estimated 
from the TEM micrographs was expected. The higher value from DLS experiments represents the 
sum  of  the  particle  radii  and  the  contribution  of  the  particle’s  surrounding  hydration  sphere, 
whereby the  TEM micrographs  only show the  size  of  the  actual  vesicle. The influence  of  the 
encapsulation of  metHb and the incorporation of  OmpF into the polymer membrane were also 
studied by TEM.  TEM micrographs of metHb-containing vesicles or metHb-containing vesicles 
with OmpF incorporated in the polymer membrane were compared to a solution of empty vesicles 
and did not  show any significant  morphological  change.  This  is  in  good agreement  with other 
protein-polymer nanoreactors based on this type of amphiphilic copolymer .74 The stability of the 
vesicles was analyzed by measuring the sample again after storage for more than three weeks at 4 
°C. The TEM micrographs revealed no significant changes. This suggests that the vesicles prepared 
from PMOXA6-PDMS90-PMOXA6 polymers are mechanically stable.
3.2.2 Protein encapsulation efficiency
The activity of the nanoreactor is affected by the encapsulation efficiency. It is important to have a 
reasonable number of Hb molecules inside the nanoreactors in order to obtain reasonable reaction 
efficiency. It is therefore important to know how many Hb molecules are encapsulated inside the 
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nanoreactors.
In order to quantify the actual amount of Hb that is encapsulated inside the  nanoreactors and the 
remaining free Hb, the sample was further analyzed.
FCS was used to determine whether metHb was encapsulated inside the vesicles or if it was only 
outside the vesicle. In addition FCS measurements performed after sample purification allowed us 
to quantify the free Hb ratio and the efficiency of separation. For these measurements, metHb was 
labeled  with  the  Alexa488  fluorescent  dye.  The  labeling  was  necessary  because  the  FCS 
measurements are based on the laser-induced fluorescence of excited fluorescent molecules. The 
fluorescent labeled Hb molecules are measured when they pass through the confocal volume. The 
signal is then auto-correlated in time and allows the calculation of the diffusion times. From the 
diffusion  times  the  size  of  the  vesicle  can  be  calculated,  because  the  encapsulated  fluorescent 
molecule has the same diffusion time as the vesicle. The hydrodynamic radius of the vesicle can be 
obtained from the diffusion time by the use of the Stokes-Einstein equation. This method has been 
used for the analysis of fluorescently-labeled proteins in nanovesicles. The labeled Hb was analyzed 
under free conditions and encapsulated in the nanoreactors. The diffusion time of the Alexa488 dye, 
the Alexa488 labeled Hb, and the encapsulated Alexa488-labeled metHb in polymer vesicles were 
measured.  The diffusion times of the Alexa488-labeled metHb encapsulated in polymer vesicles 
was compared to the diffusion time of the free Alexa488-labeled protein.110 The free Alexa488 dye 
had a diffusion time of around 26 µs, while the Alexa488-labeled metHb featured a diffusion time 
of 95 µs (Figure 23 a and b). From the diffusion time of 95 µs, the hydrodynamic radius of 2.5 nm 
for the Alexa488-labeled metHb was calculated. The calculated hydrodynamic radius of Alexa488-
metHb was in good agreement with the reported value of 3.1 nm.111 The analyzed solution contained 
vesicles  and  Alexa488-labeled  metHb.  The  obtained  data  was  fitted  for  several  different 
populations. The best fit that was obtained (Figure 23 c),  indicating the presence of two fractions 
with different diffusing times. There is a smaller fraction (2%) with a diffusing time of 95 µs and a 
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major fraction with an average diffusion time of around 6930 µs (98%). The diffusion time of 95 µs 
for the smaller fraction indicates that it is the free Alexa488-labeled metHb. The major fraction with 
a  diffusion  time of  6930 µs  corresponds  to  vesicles  with  a  calculated  hydrodynamic  radius  of 
around 170 nm ± 15 nm. The hydrodynamic radius obtained by the FCS measurements is in good 
agreement with the LS results.  To analyze whether the Hb was encapsulated in the vesicles or 
whether the Hb was attached to the outside of the vesicle, Hb was added in the same concentration 
as used for the nanoreactor preparation, to a vesicle solution that contained no Hb. The diffusion 
time of the free Alexa488-metHb was not modified by the addition of empty vesicles. This indicates 
that metHb was not attached to the outside of the polymeric membrane of the vesicles. 
Figure 23.  Autocorrelation function of free Alexa488 (a), Alexa488- metHb (b),  and  Alexa488-
metHb-containing vesicles (c)
To determine  the  encapsulation  efficiency,  we  first evaluated  the  average  number  of  Alexa488 
molecules  connected  to  one  metHb  molecule.  The  average  number  was  estimated  by the  UV 
spectra. For this, the absorption spectra of the Alexa488-labeled Hb in solution was analyzed. The 
absorption  of  the  Alexa488  was  compared  to  the  absorption  of  the  Soret  band  of  metHb.  On 
average, 2.3 dye molecules were attached per metHb molecule. The number of molecules that were 
encapsulated in the nanoreactor was calculated accordingly.
The number of Alexa488-metHb molecules per vesicle was estimated via brightness measurements. 
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In this respect, we compared the count rates per molecule (cpm, in kHz) of Alexa488, Alexa488-
metHb, and encapsulated Alexa488-metHb.
The free Alexa488 dye has a count rate of around 22.81CPM. It decreases to 14.59 CPM when the 
dye is attached to Hb molecules. The nanoreactors have an average count rate of 829.45 CPM. The 
count rate of the nanoreactors depends on the number of encapsulated Hb molecules. The count rate 
corresponded to an average of 55 molecules of Alexa488 labeled Hb. The number of Alexa488-
metHb molecules per vesicle, obtained from brightness experiments (for an initial concentration of 
metHb  of  0.47  µM/mL)  was  then  compared  to  the  theoretical  number  of  metHb/vesicle  (120 
molecules/vesicles), and resulted in an encapsulation efficiency of around 20.6 %.
3.2.3 Conclusion: Nanoreactors
Finding a good polymer that forms vesicles that are able to function as a nanoreactor is difficult. In 
order to be used for biomedical applications, nanoreactors must fulfill some crucial requirements. 
The nanoreactor has to be stable for storage; the vesicle solution has to be homogenous and the 
vesicles should not form large aggregates; the vesicles must be able to encapsulate a reasonable 
amount of guest, in our case modified Hb; the purification methods must be efficient enough to 
remove the majority of the non-encapsulated Hb. In this study we showed that nanoreactors made of 
A6B90A6 copolymer could easily be produced using the film re-hydration method. Such nanoreactors 
are  mechanically  stable  and can  be  stored for  several  weeks.  The nanoreactors  and the  empty 
vesicles did not differ by size or shape, as indicated by TEM or DLS/SLS. That shows that Hb does 
not interfere with vesicle formation. The polymer mainly forms vesicles and a smaller fraction of 
micelles, with the vesicles being the dominant species. The polymer did not form aggregates. The 
obtained  vesicles  have  an  average  radius  of  the120  nm.  A well  defined  vesicle  solution  was 
obtained.  The  FCS  data  show  that  the  purification  method  removes  nearly  all  of  the  non-
encapsulated Hb. A good encapsulation efficiency of around 20.6 %, with hardly any free Hb in the 
solution, was determined.
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3.2.4 Activity studies
For the preparation of nanoreactors it is not only important that the polymer be able to produce 
stable vesicles, but also that they incorporate Hb. Moreover, the encapsulated, active guest should 
maintain its function inside the nanoreactor. Therefore, the functionality of the nanoreactor needs to 
be demonstrated. Thus, one of the key steps in this project was to investigate the activity of the 
nanoreactor. The activity of the nanoreactor strongly depends on the activity of the encapsulated 
molecules.  One  of  the  major  differences  between  a  nanocarrier  and  a  nanoreactor  is  that  the 
encapsulated  molecules  must  retain  their  activity  inside  the  nanoreactor,  whereas  nanocarriers 
require activity upon release. On the other hand, nanoreactors do not need controlled release of the 
encapsulated  molecule.  For  every  nanoreactor,  it  is  important  to  investigate  the  activity  of  its 
encapsulated molecules. This study is important in demonstrating that the encapsulation procedure 
does not damage the hemoglobin. The encapsulation could force a change in the conformation of 
the hemoglobin that would cause a significant decrease in the activity when encapsulated. Another 
problem could arise from strong, unspecific interactions with the polymer membrane that could also 
lead to a decrease in the activity of the hemoglobin inside the nanoreactor. And yet another problem 
might be that, in order to be functional, the heme pockets of the hemoglobin must still be accessible 
to the chemicals that have to be detoxified. In our case, peroxynitrite must be able to enter the 
nanoreactor; otherwise, no detoxification could occur.
The activity was measured by changing the  oxidation state  of  Hb ( Scheme 2).  The structural 
information on the oxidation state was achieved using UV-Vis absorption spectroscopy. The Soret 
absorption band was examined for metHb, HbCO, HbO2, and deoxyHb (Figure 25 A, right). The 
other bands were used only to verify the reactions in the case of protein solution (Figure 24). We 
did not consider the other bands (between 450 nm and 600 nm) because, even if they appear in bulk 
conditions,  they  cannot  be  observed  in  the  conditions  of  the  nanoreactors  due  to  the  low 
concentration  of  the  protein  inside  nanoreactors.  The  transition  from metHb  to  deoxyHb was 
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observed by a shift in the maximum of the Soret absorption band from 405 – to 430 nm (Figure 25 
A right),  while,  for metHb to HbCO, the shift  was from 405 – to 419 nm. The conversion of 
deoxyHb to HbO2 after removal of sodium dithionite excess in the presence of oxygen has been 
demonstrated by a shift of the maximum of the Soret absorption band from 430 – to 415 nm. 76
A study  of  the  different  oxidation  states  was  not  only  important  to  show  the  activity  of  the  
encapsulated hemoglobin, but also to understand what happens on a molecular level. Because the 
different  oxidation  states  have  different  activities,  it  is  vital  to  change the  oxidation  state  in  a 
controlled way. Not all oxidation states have the same activity and therefore it is problematic when 
hemoglobin transforms into a less active state. MetHb is one of the most stable oxidation states, but 
it cannot be used for the nanoreactors. MetHb cannot carry oxygen and it is not able to react with 
peroxynitrite and cannot detoxify it.  In the bloodstream there are many substances that prevent 
HbO2 and deoxyHb from forming metHb. Without these substances, the HbO2 and the deoxyHb will 
transform into the nonreactive metHb state. 
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Scheme 2. Conversion of Hb to different oxidation states in solution and in situ inside nanoreactors.
Figure 24. UV spectra of metHb (black), HbO2 (blue), HbCO (green) and deoxyHb (red) at wave­
lengths between 350 – 750 nm
3.2.5 Free Hemoglobin
One major problem in studying the activity of hemoglobin inside nanoreactors is the fact that the 
hemoglobin  concentration  inside  the  nanoractor  is  very  low.  This  limits  the  possibilities  for 
spectroscopic measurements. Another difficulty is that the vesicles scatter light in the area where 
hemoglobin has the highest absorption, thereby affecting the final results. The redox-reaction of Hb 
can be best studied in solution. The concentrations of Hb that can be analyzed are much higher and 
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therefore the signals obtained by the analytic methods, UV/Vis and Raman, are much more reliable. 
It  is  possible  to  observe changes in  the spectra  that  could not  be observed with a  nanoreactor 
solution  because  the  signal  is  too  weak.  Another  advantage  is  that  reaction  conditions  can  be 
changed. The optimization of the reaction conditions was therefore achieved in bulk solution. The 
measurements of the redox-reaction with the Hb inside the nanoreactors were carried out in the 
same condition as in solution. The advantage of the activity measurements in solution is also that 
the results can be compared with results that are obtained by measuring the activity of hemoglobin 
inside the nanoreactors. The comparison of the data is also important because it allows predicting 
the influence of the polymer membrane. The permeability of the polymer membrane also has an 
influence,  because it  can act like a barrier  to entering molecules which,  in turn,  react with the 
molecules inside the nanoreactor.
3.2.6 Hemoglobin in nanoreactors.
After the preparation the nanoreactors were purified. The purification was necessary because most 
of the Hb present in the solution is not encapsulated in the nanoreactor. It is essential to have a good 
purification  procedure  in  order  to  get  rid  of  the  majority  of  the  free  hemoglobin.  The  non-
encapsulated Hb interferes with the measurements and provides incorrect readings,  because the 
activity  measurements  show  the  activity  of  the  whole  system  and  not  simply  that  of  the 
encapsulated hemoglobin. Therefore, it is important to reduce the amount of nonencapsulated Hb to 
a level where it does not have a significant impact. The nonencapsulated Hb was removed by SEC 
as  mentioned  previously.  The  amount  of  nonencapsulated  Hb  was  estimated  using  FCS 
measurements. The remaining, nonencapsulated Hb was minimal (2%), so it had no impact on the 
next measurements. Moreover, the purification method did not decrease the amount of nanoreactors 
obtained.
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3.2.7 Characterisation of nanoreactors reactivity
In contrast  to  the  characterisation of  the  nanoreactors  performed by TEM, DLS,  and FCS,  the 
estimation  of  the  activity  of  the  encapsulated  Hb  is  more  difficult.  A major  drawback  to  the 
investigation  of  nanoreactor  activity  was  their  low  concentration  and  the  limited  amount  of 
encapsulated Hb that was available. The limited amount of Hb significantly reduced the variety of 
analytical  methods that  could  be used to  investigate  the activity of  the  nanoreactor.  Therefore, 
Raman spectroscopy could not be used for the analysis of the oxidation state of Hb in nanoreactors. 
(The main analysis methods are based on absorption measurements in the UV region.)
The ability to change the oxidation state is crucial for the two key functions of the nanoreactor.
We chose to start with metHb, due to its stability and availability, and to convert it in situ, inside the 
nanoreactors,  to  deoxyhemoglobin (deoxyHb)  and  carbonmonoxyhemoglobin (HbCO), 
respectively, followed by the inverse reaction in the presence of peroxynitrites. Previous studies 
have  shown that  peroxynitrite  is  degraded by the  conversion  reaction  of  HbO2 to metHb. The 
conversion to different oxidation states of hemoglobin was studied with spectroscopic techniques, 
both  in  bulk  and inside  nanoreactors.  The conversion  reactions  in  bulk  served to  optimize  the 
reaction conditions previous to the encapsulation.
In order to obtain different oxidation states of hemoglobin, several different methods to convert 
metHb to HbO2, and to deoxyHb, and to HbCO(Figure 24) have been used.
3.2.8 Reducing agents
Because metHb has the highest oxidation state, there is always the need to use a reducing agent to 
convert  metHb to  a  different  oxidation  state.  The first  reducing agent  used  was ascorbic  acid. 
Ascorbic acid is present in the blood stream and is one of the natural reducing agents for Hb. The 
problems with ascorbic acid are that it is not ideal for reducing metHb, because it is not strong 
enough  to  reduce  metHb  by  itself.  Ascorbic  acid  has  to  be  used  in  combination  with  other 
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substances to reduce metHb. It is also not possible to achieve every oxidation state of Hb with 
ascorbic acid as the reducing agent. In order to achieve the more relevant oxidation states such as 
HbO2 and deoxyHb, another reducing agent has to be used. The second problem with ascorbic acid 
is that ascorbic acid is too big to penetrate the polymer membrane of the nanoreactor. It therefore 
needs  tunnel  proteins  such as  OmpF to enter  the  nanoreactor.  Because of  these  problems with 
ascorbic  acid,  sodium dithionite  was used as  a  reducing agent.  Sodium dithionite  is  a  stronger 
reducing agent then ascorbic acid. Another advantage of sodium dithionite is that it can penetrate 
the polymer membrane without the help of tunnel proteins. Sodium dithionite is strong enough to 
reduce metHb to deoxyHb when sodium dithionite is added.
The problem with sodium dithionite are that it is not stable in aqueous solution. Thus, an excess of  
sodium dithionite  had to  be added to  the metHb solution  to  completely reduce  it  to  deoxyHb. 
Sodium dithionite  is  also a  reactive species that  can interact  with the Hb.  Therefore,  if  excess 
sodium dithionite was not removed, a precipitate was observed after 10 min.
3.2.9 Reduction of free Hb
3.2.9.1 Reduction of metHb to HbCO
The first experiment was to test the activity of the Hb. It was converted from metHb to HbCO. This  
experiment showed the activity of the Hb in terms of the redox-reaction and in terms of the ability 
to bind carbon monoxide in order to investigate the binding affinity of HbCO. That showed the 
ability  of  Hb  to  form  complexes.  The  ability  to  form  complexes  is  also  important  for  gas  
transportation.
The first oxidation of metHb was performed by adding ascorbic acid to the metHb solution and then 
flushing it with carbon monoxide in order to produce HbCO. Previous experiments have shown that 
the reduction only occurs when both ascorbic acid and carbon monoxide are present. Ascorbic acid 
alone is not strong enough to completely reduce the metHb. And carbon monoxide is not able to 
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bind to metHb. In experiments where only one of these substances was present, no change in the 
UV spectra was observed. The Soret band was shifted from 405 nm to 418 nm. In this reaction, two 
things happened. The metHb was reduced by ascorbic acid and a complex with carbon monoxide 
was  formed.  When the  solution  was flushed for  a  long time,  the  formation  of  precipitate  was 
observed. MetHb can also be converted to HbCO by adding sodium dithionite and then flushing the 
solution with carbon monoxide.
3.2.9.2 Reduction of metHb to deoxyHb
The reduction of metHb to HbCO showed the activity of the Hb. But HbCO is not a reactive species 
that can be used for the transport of oxygen. In order to reduce metHb to an oxidation state that can 
bind oxygen, metHb was reduced to deoxyHb. DeoxyHb was obtained by adding an excess of 
sodium dithionite to a metHb solution. The reduction was observed by a change in the UV spectra; 
the Soret band was shifted from 405 nm to 430 nm.
3.2.9.3 Reduction of metHb to HbO2
An oxygen  carrier  has  to  be  able  to  bind  oxygen.  The  oxygen  binding  can  be  shown by the 
formation of HbO2. HbO2 is the oxidation state of Hb in which oxygen is bound to the heme group. 
The oxidation of metHb to HbO2 was more difficult, because there was no direct way to reduce 
metHb to HbO2. MetHb was first reduced to deoxyHb by addition of sodium dithionite. The excess 
of dithionite was then removed by SEC. The solution was then exposed to air. The oxygen from the 
air  binds  to  the  deoxyHb  to  form  HbO2.  The  formation  of  HbO2 was  confirmed  via  UV 
spectroscopy by a peak shift from 430 nm to 415 nm. The oxidation from deoxyHb to HbO2 was not 
observed when the excess of dithionite was not removed. In a second experiment the procedure was 
repeated in  the absence of  oxygen.  The buffer  solution was flushed with  argon to remove the 
oxygen. In this experiment no HbO2 formation was observed.
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3.2.9.4 Reduction from HbO2 to deoxyHb
For an oxygen carrier, not only is the uptake of oxygen important, it is also important to release 
oxygen. HbO2 can be reduced to deoxyHb by releasing the oxygen. In HbO2 the oxygen is bound to 
the heme group by a complex bond. The oxygen binding to the Hb is reversible.  HbO2 can be 
converted  to  deoxyHb by removing the oxygen.  The oxygen was removed from the  Hbwith a 
vacuum. The formation of deoxyHb was confirmed via UV spectroscopy by a peak shift from 415 
nm to 430 nm. By exposing the deoxyHb solution to air the deoxHb was converted back to HbO2. 
HbO2 can also be reduced to deoxyHb by adding sodium dithionite.
3.2.9.5 Conversion of HbO2 to HbCO
In addition to the reduction of HbO2 to deoxyHb, the release of oxygen can also be shown by the 
conversion from HbO2 to HbCO. HbO2 was converted to HbCO by flushing with carbon monoxide. 
The oxygen was replaced by carbon monoxide, which forms more stable complexes with Hb than 
oxygen. This experiment demonstrates that the oxygen of the HbO2 can be removed and be replaced 
with  carbon  monoxide.  This  is  important  because  it  shows  that  oxygen  can  be  released  in  a 
controlled way. The formation of HbCO was confirmed via UV spectroscopy; by a peak shift from 
415 nm to 430 nm.
3.2.9.6 Raman spectra
In  addition  to  UV-Vis  spectroscopy,  complementary  structural  information  was  obtained  using 
Raman absorption spectroscopy. The samples for the Raman measurement were prepared in the 
same way as the samples for UV-Vis measurements.
Raman spectra of the different oxidation states of Hb within the frequency range 1300 – 1900 cm -1 
were recorded (Figure 25 A left). The Raman spectra agree with the spectra already reported in the 
literature,  and the  main  peaks  have  been indexed accordingly.112-115 The  changes  in  the  Raman 
spectra are associated with conformational changes of Hb. These changes are caused by the binding 
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of ligands such as oxygen, carbon monoxide or by electron transfer.  We focused on the bands 
between 1300 and 1400 cm-1 and the region within 1500 and 1650 cm-1.The bands between 1300 
and 1400 cm-1 are named oxidation state marker bands, and the bands between 1500 and 1650 cm-1 
are named spin state marker bands.113 These bands are described in literature as the best suited to 
identify the different oxidation states. The change in the oxidation states of Hb can be observed by a 
unique  spectral  shift  of  the  relative  intensities  and  positions  of  the  peaks.115 When  metHb  is 
converted to deoxyHb or HbCO, a change in the Raman peak intensity occurs in the spin state 
marker band region. In both spectra of deoxyHb and HbCO the intensity of the peaks at 1555 and 
1610 cm-1 increased.  Therefore,  the  major  peaks  in  the  Raman spectrum of  HbCO are  largely 
similar to the major peaks of the deoxyHb spectra.116 The formation of HbO2 could not be observed 
by Raman spectroscopy. The samples that showed HbO2 in UV measurements showed deoxyHb in 
the Raman spectra. This is due to the rapid dissociation of HbO2 to deoxHb, as already reported.117 
The Raman spectra were used to confirm the oxidation state of the Hb in bulk conditions. But the 
Raman spectra could not be used for the analysis of Hb inside nanoreactors, because of the low 
concentration of Hb. 
Although the total  Hb concentration used for  nanoreactor preparation was close to 30 µM, the 
overall protein concentration in solution after purification was only100 nM. That concentration was 
far below the Raman detection limit  of 10 µM. In addition to the limited concentration of Hb, 
Rayleigh scattering from the 200 – 300 nm-size vesicles interfered greatly with spectra acquisition. 
Several  efforts  were  made  to  overcome  the  concentration  limitations,  such  as  vesicle  solution 
concentration by centrifugation. The signal can also be increased by the co-encapsulation of silver 
nanoparticles. This allows the detection of single hemoglobin molecules in the presence of silver 
nanoparticles, which have the role of enhancing the weak Raman scattering signal of the molecules 
absorbed on the metal surface, and this enhancement has previously been reported.118 The problem 
with this method is that silver nanoparticles perturb the conformation of hemoglobin’s heme pocket. 
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Figure 25. A) Raman spectra (left) for 50 µM metHb, deoxyHb and HbCO excited at 532 nm and 
the corresponding UV-Vis absorption spectra (right). B) Raman spectra and corresponding UV-Vis 
absorbance for 20 µM metHb, HbCO and HbCO in the presence of 40 µM peroxinitrite, and C) 50 
µM metHb, deoxyHb and deoxyHb in the presence of 540 µM peroxynitrite. 
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3.2.10Reduction of Hb in Nanoreactors.
After the studies of Hb in solution, the redox-reactions were repeated with a nanoreactor solution. 
The reactions were done in the same manner and under the same conditions as the experiments in 
bulk conditions. Only the amount of reducing agents was lowered, in order to have the same ratio as 
under  bulk conditions.  The results  were compared with  the results  from the redox-reactions  in 
solution.
3.2.10.1Reduction of metHb to HbCO
The oxidation of metHb was performed by addition of ascorbic acid to the nanoreactor solution and 
it was then flushed with carbon monoxide in order to produce HbCO. The experiment was done 
with nanoreactors that contain OmpF in their membranes, and with nanoreactors without OmpF 
incorporated in their membranes. UV measurements showed that, for nanoreactors without OmpF, 
no reaction occurred; the Hb encapsulated in nanoreactors remained unchanged as MetHb. The 
reason  for  this  is  that  ascorbic  acid  is  not  able  to  penetrate  the  polymer  membrane  of  the 
nanoreactor.  When the nanoreactor  contains  OmpF,  the ascorbic  acid can enter  the nanoreactor 
through the OmpF tunnel protein. In the experiment with the OmpF-containing nanoreactors the 
formation of HbCO was observed, due to the presence of ascorbic acid. This proves that OmpF is  
incorporated in the polymer membrane (Figure 26). The experiment also showed that all of the Hb 
is encapsulated in the nanoreactor. Otherwise, the ascorbic acid would have reacted with the free 
Hb, and the formation of HbCO would have been observed in both experiments. HbCO could also 
be obtained by using sodium dithionite  instead of  ascorbic  acid.  The difference is  that  sodium 
dithionite is able to penetrate the polymeric membrane of the nanoreactor. In that case it makes no 
difference if the hemoglobin is encapsulated or not.
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Figure 26. A. Normalized UV-Vis spectra of metHb-containing nanoreactors with OmpF inserted in 
the membrane: before (black), and after flushing the solution with carbon monoxide (red). B. UV-
Vis  spectra  of  metHb-containing nanoreactors  without  OmpF inserted in  the membrane:  before 
(black), and after flushing with carbon monoxide (red).
3.2.10.2Reduction of metHb to deoxyHb
The reduction of metHb to deoxyHb can be performed in the same manner as under free conditions 
by addition of sodium dithionite. This reaction is fast and leads to a complete reduction of the  
metHb.  The  conversion  can  be  observed  by a  peak  shift  from 405  to  430  nm.  Since  sodium 
dithionite  is  used  for  this  reaction,  there  is  no  need  to  incorporate  OmpF  in  the  polymeric 
membrane. The same problem that occurs in free solution also occurs in nanoreactors. The problem 
is that an excess of sodium dithionite has to be used in order to convert metHb to deoxyHb. If the 
excess of sodium dithionite is not removed from the solution, the nanoreactors precipitate.
3.2.10.3Conversion of metHb to HbO2
For the conversion of metHb to HbO2, metHb had to be reduced to deoxyHb first. This was done in 
the same way as in the previous reactions. Therefore, an excess of sodium dithionite was also added 
to the metHb solution. For the oxidation from deoxyHb to HbO2 the excess of sodium dithionite  
had to be removed. The removal of the sodium dithionite from a nanoreactor solution was difficult. 
The  problem  was  that,  after  the  purification  step,  where  the  free  Hb  is  removed,  the  Hb 
concentration in the nanoreactor solution is very low. A second purification where the excess of 
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sodium dithionite is  removed would even further decrease the Hb concentration.  Therefore,  the 
sodium dithionite  was added to the nanoreactor  solution before the purification.  The excess  of 
sodium dithionite and the non-encapsulated Hb were removed at the same time. After the removal  
of the excess of dithionite the deoxyHb reacted with the oxygen present in the buffer to form HbO2 
(Figure 27). If a degassed buffer was used for the purification, deoxyHb did not convert to HbO2.
Figure 27. UV spectra  of metHb-containing nanoreactors:  before addition of sodium dithionite 
(black), after addition of sodium dithionite in excess (red), and after removal of sodium dithionite 
excess (blue).
3.2.10.4Conversion of HbO2 to HbCO
One requirement for oxygen carriers is that the oxygen can be released from the nanoreactor in a 
controlled way. In order to prove that oxygen is released from the nanoreactor, the oxygen bound to 
the encapsulated HbO2 was removed. The oxygen was removed by flushing the nanoreactor solution 
with carbon monoxide. Carbon monoxide binds to the Hb and replaces the oxygen. The prepared 
HbO2 solution was converted to HbCO by flushing with carbon monoxide for 10 min. The oxygen 
was replaced by carbon monoxide that forms more stable complexes with Hb than oxygen. The 
reaction was observed by a peak shift from 415 nm to 419 nm.
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3.2.10.5Reduction from HbO2 to deoxyHb
The reduction from HbO2 to deoxyHb was another experiment that was conducted in order to show 
that oxygen can be removed from the encapsulated Hb in a controlled way. The aim was to reduce 
HbO2 to deoxyHb by removing the oxygen with a vacuum. This was successfully done under bulk 
conditions. But the concentration of Hb in the nanoreactor solution is extremely low; therefore, it 
was not possible to remove enough oxygen from the solution to convert a significant amount of 
HbO2 to deoxyHb.
3.2.11 Conclusion: metHb Reduction
The reduction of metHb to the different oxidation states can be achieved in nanoreactors in a similar 
way as under free conditions. The reduction of metHb with ascorbic acid and carbon monoxide is 
different from the other reducing procedures. This reaction requires that OmpF be incorporated in 
the polymeric membrane of the nanoreactor. If sodium dithionite is used instead of ascorbic acid, 
the conversion can be done without the incorporation of OmpF in the polymer membrane, because 
sodium dithionite is able to penetrate the polymer membrane. Sodium dithionite also reacts fast 
with  the  encapsulated  Hb  and  reduces  it  to  deoxyHb.  The  metHb  can  be  easily  converted  to 
deoxyHb and HbCO. Having it  convert  to  HbO2 was a  bit  more difficult,  because of the low 
concentration  of  the  Hb in  the  nanoreactor  solution.  The low concentration  of  the  nanoreactor 
solution made it more difficult to remove the excess of sodium dithionite by SEC. It was shown that  
the  hemoglobin  inside  the  nanoreactor  can  be  reduced  to  an  active  oxidation  state.  Therefore, 
encapsulated Hb retained its functionality unaffected.
The biggest problem in converting Hb in nanoreactors to the different oxidation states is the low 
concentration  of  the  Hb  in  the  nanoreactor  solution.  That  reduces  the  stability  with  regard  to 
reactive species such as sodium dithionite. That could reduce the amount of intact Hb to a level at 
which  it  cannot  be  detected.  That  also  happened  when  the  nanoreactor  solution  was  flushed 
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extensively with  carbon monoxide  or  oxygen.  Thus,  the  reaction conditions  have to  be chosen 
carefully to get a complete conversion without destroying the Hb inside the nanoreactors. Another 
problem  was  the  limited  amount  of  nanoreactor  solution  that  was  available.  This  makes  a 
concentration of the nanoreactors through centrifugation nearly impossible. Even the concentrated 
nanoreactor solution contained so little Hb that it was not suitable for most of the experiments.
With the right reaction conditions the encapsulated Hb was able to be reduced to every oxidation 
state with only minimal losses.
3.2.12Peroxynitrite degradation 
One of the main functions of the nanoreactors is the degradation of peroxynitrite. The degradation 
of  peroxynitrite  occurs  when  the  peroxynitrite  reacts  with  the  encapsulated  Hb.  Therefore,  the 
reaction between the peroxynitrite and the different oxidation states of Hb were studied.
 In this reaction the Hb is oxidized and the peroxynitrite is then degraded. The previous studies on 
the reduction of metHb to an active oxidation state are important for the study of the reaction with 
peroxynitrite. The reaction of peroxynitrite with different oxidation states was studied extensively.
We chose to start with metHb because of its stability and availability, and its ability to be converted 
in situ, inside the nanoreactors, to deoxyHb and HbO2. Previous studies showed that peroxynitrite is 
degraded by the conversion reaction of HbO2 to metHb via the corresponding oxoiron(IV) of the 
hemoglobin protein (Scheme 3). 
Scheme 3.  Peroxynitrite  degradation by the conversion reaction of oxyHb (Fe(II)O2)  to metHb 
(Fe(III)).
We studied  the  reaction  of  peroxynitrite  with  the  different  oxidation  states  of  hemoglobin.The 
experiments  were  performed  in  solution,  and  inside  nanoreactors  (Figure  28).  The  conversion 
reactions  of  free  hemoglobin  in  solution  served  to  optimize  the  conditions  previous  to  the 
encapsulation. 
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Figure 28. Schematic representation of the degradation of peroxynitrite with the use of nanoreactors. 
3.2.13Oxidation of deoxyHb, HbO2 and HbCO
In free solution the previously prepared deoxyHb was converted back to metHb by adding an excess 
of peroxynitrite to the deoxyHb solution. The conversion was observed by a peak shift in the UV 
spectra from 430 nm to 405 nm as well as by a change in the Raman spectrum. For a complete 
conversion, an excess of peroxynitrite was required. The reaction of HbO2 with peroxynitrite was 
similar to the reaction of peroxynitrite with deoxyHb. There was also a peak shift in the UV spectra 
from 415 nm to 405 nm and a change in the Raman spectrum was observed. In addition to the two 
oxidation states that were important for the function of the nanoreactor, HbCO was also oxidized 
with peroxynitrite. This conversion was observed by a peak shift in the UV spectra from 419 nm to 
405 nm and by a change in the Raman spectrum. All of the different oxidation states were able to be 
converted to metHb by adding peroxinitrite.
After  the  experiments  had  been  done  under  free  conditions,  they  were  also  been  done  in 
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nanoreactors.
In nanoreactors,  deoxyHb was converted back to  metHb by adding an  excess  of  peroxynitrite.  
DeoxyHb was oxidized rapidly by the addition of peroxynitrite. Experiments with nanoreactors that 
did not contain OmpF showed that peroxynitrite is able to pass through the polymeric membrane 
without the need for tunnel proteins. In addition to deoxyHb, HbO2 was also converted back to 
metHb by addition of an excess of peroxynitrite (Figure 29). HbO2 was oxidized rapidly after the 
addition of peroxynitrite. HbCO was also converted back to metHb by the addition of an excess of 
peroxynitrite. The reaction between peroxynitrite and the different oxidation states of Hb is a redox-
reaction, where the peroxynitrite is reduced and the different oxidation states of Hb are oxidized. 
Hb is oxidized to metHb because it is the highest oxidation state. The oxidation to metHb was 
observed  by a  peak  shift  in  the  Soret  band  to  405  nm under  free  conditions  and  408  nm in 
nanoreactors. The slight shift of the maximum of the absorption band of metHb from 405- to 408 
nm was already observed when metHb was encapsulated in a silica matrix 123 or immobilized on a 
glass surface.124 The degradation of peroxynitrite can be observed by a reduction of the peak at 302 
nm. The problem with the observation of the peroxynitrite degradation is that peroxynitrite degrades 
fast. This happens especially under acidic or neutral conditions, and peroxynitritre is also unstable 
at higher temperatures. Because the concentration of Hb in the nanoreactor solution is really small, 
it  is  best  to  not  monitor  the  change  at  302  nm;  instead,  the  change  in  the  absorption  peak 
characteristic for deoxy-Hb should be quantified.
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Figure 29. UV spectra of HbO2-containing nanoreactors before (black), and after addition of perox­
ynitrite (red). 
3.2.14Hb extracted from fresh blood
In our experiments, commercially available lyophilized blood was used to form nanoreactors.
In order to analyze the activity of the commercially available lyophilized blood, the commercial Hb 
was compared to a sample of freshly extracted blood. The main oxidation state of the Hb in fresh 
blood is HbO2. This was compared with the HbO2 that was produced by oxidation of metHb. The  
fresh Hb was also converted to deoxyHb by the addition of sodium dithionite as well as converted 
to  metHb  by  the  addition  of  peroxynitrite.  The  freshly  extracted  Hb  reacted  similarly  to  the 
commercially available lyophilized blood sample.
3.2.15Conclusion: Peroxynitrite degradation
The reactions of the encapsulated Hb with the peroxynitrite in nanoreactors were in good agreement 
with the experiments that were conducted under bulk condition. The peak shifts of the Soret band 
that were observed under bulk conditions were also observed in the nanoreactors, while the peak 
shifts in the other regions could not be observed because of the low Hb concentration. All of the 
oxidation states except for metHb showed a reaction with the peroxynitrite – under free conditions 
68
as well as in nanoreactors. It was shown that peroxynitrite reacts with the encapsulated Hb and is 
therefore  degraded.  In  this  reaction,  Hb  is  oxidized  and  the  peroxynitrite  is  degraded.  These 
reactions were important to verify the function of the nanonreactors. Peroxynitrite is also able to 
pass through the polymeric membrane without the need for tunnel proteins. Peroxynitrite reacts fast 
with the encapsulated Hb and oxidizes it to metHb. All oxidation forms were able to be completely 
oxidized to metHb, which shows that all of the encapsulated Hb was active. It was shown that the 
behavior of Hb encapsulated in nanoreactors was not different to the Hb in free solution.  That 
proves  that  the  nanoreactors  have  the  ability  to  degrade  peroxynitrite.  These  experiments  also 
showed that the previous reduction methods are reversible.
3.2.16Kinetics of peroxynitrite degradation
Using UV and Raman spectroscopy, the  change in the Hb oxidation state could be shown both 
under free conditions and inside the nanoreactors. That is why the two spectroscopic methods can 
be employed to study how the polymeric membrane of the nanoreactor influences the Hb reaction 
kinetics. The UV spectra are not adequate to prove that an Hb encapsulating nanoreactor degrades 
peroxynitrite fast enough. Kinetic data were required to show how fast peroxynitrite was degraded 
inside  the  nanoreactors.  If  the  encapsulation  of  Hb in  nanoreactors  reduces  the  activity  of  the 
encapsulated Hb too much, then it does not fulfill the purpose of peroxynitrite degradation. In order 
to  distinguish  the  mechanism  of  the  peroxynitrite  degradation,  various  kinetics  studies  on 
hemoglobin, peroxynitrite, and the intermediate species that are involved have been performed.121, 
The low concentration of Hb in the nanoreactor solution allowed only the study of the characteristic 
heme Soret band. Because of this limitation and considering the requirements of the project-related 
peroxynitrite degradation, we focused on a different approach. This study allowed us to characterize 
and quantify the activity of hemoglobin-containing nanoreactors, and the overall influence of the 
polymeric membrane. The study was mainly focused on the formation and degradation of deoxyHb. 
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In  order  to  follow the  reaction  inside  nanoreactors,  we used  the  wavelength  of  the  absorption 
maximum of deoxyHb at 430 nm, and not the absorption bands at 586 nm or 609 nm, because of 
their low extinction coefficients. This limitation prevented us from demonstrating the presence of 
the ferryl intermediate already proposed by Exner.121 Despite this limitation, we were able to obtain 
a rate constant value that fully characterizes the degradation process of peroxynitrite mediated by 
the nanoreactor. Because of the very small difference between the rate constants for the two steps of 
the reaction, the kinetic studies were performed both with Hb in solution and in nanoreactors. The 
reaction kinetics was then compared in order to estimate the influence of the polymeric membrane. 
The first kinetic study was related to the formation of deoxyHb from metHb. By the addition of 
sodium dithionite to both free metHb and to a solution with nanoreactors containing metHb,  the 
metHb was reduced to deoxyHb.
The absorption from the nanoreactor solution was higher than from the solution containing free Hb, 
because of light scattering from the nanoreactors. The obtained kon value for the conversion reaction 
of metHb to deoxyHb in the case of free Hb (4.42 *106 M-1 s-1) was similar to that of encapsulated 
Hb in  the  nanoreactors  (kon of  4.19  *  106  M-1 s-1)  (Figure 30 A).  This  similarity leads  to  the 
assumption that the polymeric membrane does not influence the reaction kinetics. This result was 
expected because of the permeability of the polymer membrane. In a second experiment, deoxyHb 
was  converted  to  metHb by the  reaction  with  peroxynitrite.  This  experiment  was  done by the 
addition of peroxynitrite to free deoxyHb, and to deoxyHb-containing nanoreactors. In this reaction, 
a decrease in the absorption at the absorption maximum for deoxyHb of 430 nm was observed. 
The  decrease  was  observed  under  free  conditions  and  inside  nanoreactors.  This  indicates  that 
deoxyHb was converted to a different oxidation state. The obtained kon value of 2.75 * 104 M-1 s-1 for 
free Hb in solution was also similar to the kon value of 2.28 * 104 M-1 s-1 (Figure 30 B) for Hb inside 
nanoreactors. The values were also in good agreement with the values previously reported for this 
reaction in free human Hb solution (2.9 x 104 M-1s-1 for an Hb concentration of 3.0 µM).122 In 
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addition, the peroxynitrite degradation inside red blood cells (RBC), mediated by oxyHb present at 
a 5 mM concentration, has a rate constant kon of 1.7x104 M-1 s-1 at 37˚C and pH 7.4,127 which is on 
the same order of magnitude as the rate constant that we obtained both for free Hb and for the 
nanoreactors.  Peroxynitrite  degradation  was  also followed  at  302  nm,  the  maximum  of  the 
absorbance band for peroxynitrite (Figure 31) .75 The kinetic measurements show that Hb is still 
active inside the nanoreactors. 
Figure 30.  A. Normalized trace of the conversion of encapsulated metHb (red) and free metHb 
(black) with 1 mmol/L sodium dithionite solution. B. Normalized trace of the conversion of encap­
sulated deoxyHb (red) and free deoxyHb (black) with 10 mmol/L peroxynitrite solution.
Figure 31. The degradation of peroxynitrite was analyzed with stopped flow at a wavelength of 302 
nm. The peroxynitrite solution showed a strong degradation with a kon of 3.18 * 104 M-1 s-1 after ad­
dition of a deoxyHb solution. These measurements were done with unencapsulated Hb.
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3.2.17Oxygen transport
The main advantage of using Hb for detoxification of peroxynitrite is that Hb is well known for its 
ability to carry oxygen. Therefore, as hemoglobin is the active part of our nanoreactors, we also 
tested them as oxygen carriers. But there are specific conditions that have to be fulfilled in order to 
prove that Hb has the ability to carry oxygen. One important condition is the selected oxidation 
state of the Hb. In the blood stream, HbO2 and deoxyHb are both present, and deoxyHb is able to 
take up oxygen while HbO2 releases oxygen. MetHb is not able to bind oxygen. One of the main 
problems with hemoglobin-based oxygen carriers is that HbO2 is rapidly oxidized to metHb when 
outside of physiological conditions. In the bloodstream, reducing agents such as ascorbic acid are 
present,  preventing  Hb  from being  oxidized  to  metHb.  To  avoid  metHb  formation  inside  the 
nanoreactors, previous studies show that various enzymes, such as carbonic anhydrase, catalase, and 
superoxide dismutase,  were co-encapsulated together  with hemoglobin.56  The problem with this 
approach is that it increases the complexity of the system. This is problematic because the control of 
the necessary enzyme amount  inside the carrier  is  limited.  Therefore,  this  system is  extremely 
difficult to optimize, especially for medical applications. 
The advantage of our system is that it does not require co encapsulation of other  enzymes. Our 
nanoreactors  feature  the advantage  that  OmpF can be inserted in  the  polymer  membrane.  This 
allows the free passage for molecules with a mass up to 600 Da into the nanoreactor. Therefore,  
reducing agents  such as ascorbic  acid  or  glutathione,  which  are  present  in  the  plasma,  128 can 
penetrate through the polymer membrane. These reducing agents support the conversion of metHb 
to  deoxyHb.  Therefore,  the  presence  of  a  co  encapsulated  enzyme is  not  required  in  case  the 
concentration of the reducing agent in vivo is sufficient. The nanoreactors can be modified by co-
encapsulation  of  a  second  biomolecule,  for  example  NADH-cytochrome  b5,  known  to  reduce 
metHb in red blood cells.129 
To establish the oxygen transport ability of Hb,  the uptake and release of oxygen was studied in 
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solution and in nanoreactors.  The oxygen uptake was proven by the conversion of deoxyHb to 
oxyHb. This was demonstrated  when a solution of deoxyHb-containing nanoreactors was passed 
through a column to remove the excess sodium dithionite. This experiment was done under argon 
and in the presence of oxygen. The sample was then analyzed by UV-Vis. In the experiment that 
was done in the presence of oxygen, the maximum of the Soret absorption band shifted to 415nm. 
In the experiment done without oxygen, no peak shift was detected. The peak shift indicated the 
formation of HbO2, and therefore proved that oxygen is binding to the heme pocket of the Hb inside 
nanoreactors. 
The  release  of  oxygen  from  the  Hb-containing  nanoreactors  was  shown  by  flushing  the 
nanoreactors solution with carbon monoxide. This is a slightly modified approach as compared to 
that reported by Sakai et al.130 The carbon monoxide replaces the oxygen that is bound to the heme 
pocket. After the flushing, a shift in the maximum Soret absorption band was observed. That proves  
that  HbCO  was  formed  both  under  free  protein  conditions,  and  when  encapsulated  in  the 
nanoreactors (Figure 32).
Figure 32. A. UV spectra of HbO2 solution before flushing with carbon monoxide (black), and af­
ter flushing with carbon monoxide (red). B. UV spectra in the domain of Soret absorption band of 
HbO2 containing nanoreactors, with OmpF inserted into the polymer membrane before flushing 
with carbon monoxide (black), and after flushing with carbon monoxide (red).
These experiments also showed that oxygen binding is not affected by the width of the polymeric 
membrane. This is due to the chemical nature of the  PMOXA-b-PDMS-b-PMOXA copolymers, 
which do not interact with Hb, and to their intrinsic permeability to oxygen species, which does not  
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limit the penetration of oxygen. 
We  have  proven  the  functionality  of  our  nanoreactors  separately in  both  the  degradation  of 
peroxynitrites and in the transport of oxygen. These processes run inversely in terms of oxygenated 
Hb species, one inducing their consumption, the other requiring them to be at a stable concentration. 
Therefore, co-encapsulation of a reducing biomolecule in tandem with Hb favors the oxygen carrier 
function. The co-encapsulation should be carefully optimized (so as not to obstruct the peroxynitrite 
degradation  function.)  Depending on the  intended medical  application,  one  or  the  other  of  the 
nanoreactors functions is expected to play the major role.
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4 General Conclusion
In this thesis, we have introduced the results gathered in two different principal projects. The first  
project required producing a responsive polymer brush that provides dual-functionality: surface pas­
sivation and selective binding sites for specific molecules. In order to create a polymer brush with 
specific functions, we used a polymer with branched architecture. The advantage of that architecture 
is the potential for further modification and copolymerization, which allows for the incorporation of 
specific binding sites for various molecules.
The polymer was successfully synthesized with ARGET ATRP. The polymer was deposited on the 
surface via the “grafting to” method. The polymer was shown to be efficient in passivation. The 
surface passivation abilities were confirmed with SPR and QCM. In addition to the passivation, the 
system also provides many possible binding sites. Antibody binding was demonstrated with SPR. 
Using  this  technique,  high  selectivity  was  achieved  with  interesting  results  in  terms  of  low 
unspecific binding and high specific binding.  In the second project, functional nanoreactors were 
developed.  The  nanoreactors  have  dual-functionality:  the  detoxification  of  peroxynitrites  and 
oxygen transport.
The degradation of peroxynitrite and oxygen  transport are relevant for medical applications. The 
peroxynitrite degradation is important, because peroxynitrite is a reactive oxidative species that is 
involved in various pathologic conditions. In addition, the nanoreactors have the ability to carrier 
oxygen  and  to  serve  as  artificial  blood.  Nanoreactors  were  formed  by  the  self-assembly  of 
PMOXA-b-PDMS-b-PMOXA copolymers. Hb was encapsulated in the nanoreactors. Hemoglobin 
was used as a model protein, because of its ability to provide the dual functionality of transporting 
oxygen  and  degrading  peroxinitrites.  It  was  shown  that  the  encapsulated  Hb  preserved  its 
functionality  inside  the  nanoreactor.  The  preservation  of  functionality  is  based  on  the  mild 
encapsulation procedure.  The self-assembly process  used for  vesicle  formation was done under 
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physiological conditions for hemoglobin and does not affect this protein’s activity.
The activity  of  the  encapsulated  Hb was shown by the  conversion  reactions  involving various 
oxidation states of hemoglobin, such as HbO2, HbCO and deoxyHb. The changes in oxidation states 
were  reversible.  The  high  activity  of  the  nanoreactor  is  not  only  due  to  the  activity  of  the 
encapsulated Hb. It was also demonstrated that channel porins can be inserted into the polymer 
membrane and these channel porins serve as gates for molecules such as peroxynitrite or oxygen.
We demonstrated  that  encapsulated HbO2 and  deoxyHb react  with environmental  peroxynitrite, 
resulting in the degradation of peroxynitrite. The data obtained from the kinetic measurements are 
in good agreement with the literature. The data also allowed a comparison of the reaction kinetics of 
encapsulated Hb and free Hb. The reaction kinetics of the free Hb is not significantly different from 
the reaction kinetics of the encapsulated Hb. This proves that the Hb inside the nanoreactor is active 
and the reaction kinetics of the encapsulated Hb is not decreased. In addition, the ability to function 
as an oxygen carrier has been proven by demonstrating that oxygen can be taken up and released 
inside nanoreactors. Because of the stability of the of  PMOXA-b-PDMS-b-PMOXA vesicles, the 
nanoreactors maintain their function for an extended period of time.
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6 Abbreviations and symbols
% percent
°C degree celsius
ARGET activators regenerated by electron transfer
ATRP atom transfer radical polymerization 
ATR-IR attenuated total reflection infrared (spectroscopy)
DLS Dynamic light scattering 
DMF dimethylformamide
DNA deoxyribonucleic acid 
FCS fluorescence correlation spectroscopy
GPC gel permeation chromatography
Hb Hemoglobin
HEA 2-hydroxyethyl acrylate
1HNMR nuclear magnetic resonance
k reaktionskonstante
kD dissoziationskonstante
kDa kilo Dalton
LbL Layer by Layer 
Mn number average molecular weight
Mw weight average molecular weight
OmpF Outer membrane protein F
PBS phosphate buffered saline
PDI polydispersity index
PDMS Polydimethylsiloxan
PEG poly(ethylene glycol) 
PEGA poly(ethylene glycol)methyl ether acrylate 
viii
PFCs perfluorochemicals 
PMOXA poly(2-methyl-2-oxazoline)
QCM Quartz crystal microbalance
Rg radius of gyration
RH hydrodynamic radius
ROS reactive oxygen species
SEC Size-exclusion chromatography
SLS Static light scattering
SOD Superoxide dismutase
SPR surface plasmon resonance (spectroscopy)
TEM transmission electron microscopy
UV UV/VIS-Spektroskopie
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